Processing 00000000.tx.1: Presenilin 2Interacts with Sorcin, a Modulator of the Ryanodine Receptor* Eunju Pack-Chung, Marian B. 

Phrase: "Presenilin 2Interacts with Sorcin,"

Phrase: "a Modulator of the Ryanodine Receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709060:Modulator [Manufactured Object]

Phrase: "* Eunju Pack-Chung,"

Phrase: "Marian B."
Processing 00000000.tx.2: Meyers, Warren P. 

Phrase: "Meyers,"

Phrase: "Warren P."
Processing 00000000.tx.3: Pettingell, Robert D. 

Phrase: "Pettingell,"

Phrase: "Robert D."
Processing 00000000.tx.4: Moir, Amy M. 

Phrase: "Moir,"

Phrase: "Amy M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: Brownawell, Isaac Cheng**, Rudolph E. 

Phrase: "Brownawell,"

Phrase: "Isaac Cheng"

Phrase: "*"

Phrase: "*,"

Phrase: "Rudolph E."
Processing 00000000.tx.6: Tanzi, and Tae-Wan Kim From the Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129,the Department of Medicine, Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029,and the Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Perturbed Ca2+ homeostasis is a common molecular consequence of familial Alzheimer's disease-linked presenilin mutations. 

Phrase: "Tanzi,"

Phrase: "and"

Phrase: "Tae-Wan Kim From the Genetics"

Phrase: "and"

Phrase: "Aging Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Charlestown,"

Phrase: "Massachusetts 02129,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "the Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Cardiovascular Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10029,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "the Department of Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of Virginia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0042753:Virginia [Geographic Area]
   827   C1256310:Virginia [Reptile]

Phrase: "Charlottesville,"

Phrase: "Virginia 22908  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Perturbed Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019868:Homeostasis [Biologic Function]

Phrase: "is"

Phrase: "a common molecular consequence of familial Alzheimer's disease-linked presenilin mutations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0686907:Consequence of [Functional Concept]
           Consequence
Processing 00000000.tx.7: We report here the molecular interaction of the large hydrophilic loop region of presenilin 2(PS2) with sorcin, a penta-EF-hand Ca2+-binding protein that serves as a modulator of the ryanodine receptor intracellular Ca2+ channel. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the molecular interaction of the large hydrophilic loop region of presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167622:Molecular Interaction [Molecular Function]
   751   C2936292:Interaction, Hydrophilic [Molecular Function]
   736   C1704675:Interaction [Functional Concept]

Phrase: "(PS2"

Phrase: ")"

Phrase: "with sorcin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "a penta-EF-hand Ca2+-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "serves as a modulator of the ryanodine receptor intracellular Ca2+ channel."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1753335:ryanodine receptor [Molecular Function]
   738   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   738   C0175996:intracellular [Cell Component]
   738   C0178719:Intracellular [Spatial Concept]
   738   C0439799:Channel [Spatial Concept]
   738   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1706095:Channel [Conceptual Entity]
   738   C1709060:Modulator [Manufactured Object]
Processing 00000000.tx.8: The association of endogenous sorcin and PS2 was demonstrated in cultured cells and human brain tissues. 

Phrase: "The association of endogenous sorcin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "PS2"

Phrase: "was"

Phrase: "demonstrated in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "human brain tissues."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0440744:human tissues [Tissue]
   901   C0440746:brain tissues [Tissue]
   867 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissues [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.9: Membrane-associated sorcin and a subset of the functional PS2 complexes were co-localized to a novel subcellular fraction that is distinctively positive for calcineurin B.Sorcin was found to interact with PS2 endoproteolytic fragments but not full-length PS2, and the sorcin/PS2 interaction was greatly enhanced by treatment with the Ca2+ ionophore A23187. 

Phrase: "Membrane-associated sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "a subset of the functional PS2 complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "were"

Phrase: "co-localized to a novel subcellular fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0038528:Subcellular Fraction [Cell Component]
   748   C0205314:Novel [Temporal Concept]
   748   C0392752:Localized [Spatial Concept]
   748   C0679622:novel [Intellectual Product]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "distinctively positive for calcineurin B.Sorcin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with PS2 endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not full-length PS2,"

Phrase: "and"

Phrase: "the sorcin/PS2 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "greatly"

Phrase: "enhanced by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C2349975:Enhanced [Activity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with the Ca2+ ionophore A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.10: Our findings reveal a molecular link between PS2 and intracellular Ca2+ channels (i.e. ryanodine receptor) and substantiate normal and/or pathological roles of PS2 in intracellular Ca2+ homeostasis.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a molecular link between PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "intracellular Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(i.e. ryanodine receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "and"

Phrase: "substantiate"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and/or"

Phrase: "pathological roles of PS2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "in intracellular Ca2+ homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Nearly half of early-onset familial Alzheimer's disease (FAD)1 is associated with mutations in genes encoding two homologous proteins, presenilin 1(PS1) and presenilin 2(PS2) (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nearly half of early-onset familial Alzheimer's disease (FAD)1"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   858   C0338445:Familial Alzheimer's disease of early onset [Disease or Syndrome]
   807   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   790   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   790   C2931257:Alzheimer disease 1 [Disease or Syndrome]
   781   C0814120:early disease onset [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   764   C1833334:Early-onset [Finding]
   762   C0277558:Familial disease [Disease or Syndrome]
   762   C0277793:disease onset [Temporal Concept]
   762   C0679245:early disease [Temporal Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0241888:Familial [Functional Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C1279919:Early [Temporal Concept]
   742   C2825407:Half [Quantitative Concept]
   736   C1425075:MALS-1 [Gene or Genome]
   726 E C0344339:disease family [Finding]

Phrase: "is"

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "two homologous proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS2"

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Recent studies have shown that PS1 (and perhaps PS2) plays an essential role in the -secretase cleavage of amyloid -protein precursor (2-4) and the trafficking/maturation of other select cellular proteins, including Notch and TrkB (5-8). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "("

Phrase: "and"

Phrase: "perhaps PS2"

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in the -secretase cleavage of amyloid -protein precursor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "/maturation of other"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0678723:Maturation [Organism Function]
   790   C0870861:maturation [Phenomenon or Process]
   790   C1254042:Maturation [Physiologic Function]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "cellular proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "and"

Phrase: "TrkB"

Phrase: "(5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: Common molecular consequences of presenilin FAD mutations include the increased production of amyloid -peptide x-42 and increased apoptosis (reviewed in Refs. 9-11). 

Phrase: "Common molecular consequences of presenilin FAD mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the increased production of amyloid -peptide x-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "increased apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in Refs. 9-11"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0282443:reviewed [Intellectual Product]
   760   C1425988:REF [Gene or Genome]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.14: In addition, FAD mutations in both PS1 and PS2 have been shown to disrupt intracellular Ca2+ homeostasis (12, 13). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "FAD mutations in both PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "PS2"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "intracellular Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019868:Homeostasis [Biologic Function]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.15: However, the mechanism by which Ca2+ dyshomeostasis contributes to FAD pathogenesis is still unresolved. 

Phrase: "However,"

Phrase: "the mechanism by which Ca2+ dyshomeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "contributes to FAD pathogenesis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277558:Familial disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1880177:Contribute [Activity]
   748 E C0344339:disease family [Finding]

Phrase: "is"

Phrase: "still unresolved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443342:Unresolved [Qualitative Concept]
Processing 00000000.tx.16: Recently, a number of molecules that form complexes with the presenilins have been identified, including - and -catenin (14-19), p0071 (20), amyloid -protein precursor (21), filamin/Fh-1 (22), Notch (23), GSK3 (24), Rab11 (25), calsenilin (26), calmyrin (27), QM/Jif-1 (28), and Bcl-XL (29). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a number of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "complexes with the presenilins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "-"

Phrase: "and -"

Phrase: "catenin"

Phrase: "(14-19"

Phrase: ")"

Phrase: ","

Phrase: "p0071"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418615:p0071 [Gene or Genome]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "amyloid -protein precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "filamin/Fh-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1414635:FILAMIN 1 [Gene or Genome]
   913   C1612831:Filamin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0060383:Filamin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "Rab11"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "calsenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0758551:Calsenilin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1825644:CALSENILIN [Gene or Genome]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "calmyrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424635:CALMYRIN [Gene or Genome]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "QM/Jif-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439507:QM [Temporal Concept]
   827   C1335635:QM [Gene or Genome]
   827   C1705025:QM [Gene or Genome]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Bcl-XL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.17: It is currently unclear whether these interactions mediate pathogenesis in presenilin FAD. 

Phrase: "It"

Phrase: "is"

Phrase: "currently unclear"

Phrase: "whether"

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "pathogenesis in presenilin FAD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.18: It is also noteworthy that some of these proteins have been shown to interact either preferentially or exclusively with full-length presenilin over the N- or C-terminal fragments. 

Phrase: "It"

Phrase: "is"

Phrase: "also noteworthy"

Phrase: "that"

Phrase: "some of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact"

Phrase: "either preferentially"

Phrase: "or"

Phrase: "exclusively with full-length presenilin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0443225:Full [Qualitative Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "over the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "or"

Phrase: "C-terminal fragments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.19: Since only a subset of presenilin proteins are cleaved to form stable, functional presenilin complexes (30-35), and the remaining full-length proteins are degraded by the proteasome (32, 36-38), proteins that interact with the N- and/or C-terminal presenilin fragments are more likely to mediate presenilin function as opposed to maturation of the presenilins. 

Phrase: "Since only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1711239:Since [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a subset of presenilin proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "are"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "stable, functional presenilin complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "(30-35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the remaining full-length proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "degraded by the proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(32,"

Phrase: "36-38"

Phrase: ")"

Phrase: ","

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact with the N-"

Phrase: "and/or"

Phrase: "C-terminal presenilin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "presenilin function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "opposed to maturation of the presenilins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   753   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.20: Additionally, many of these presenilin-interacting proteins have been identified and characterized using overexpression in cell systems, whereas only a few have been demonstrated to interact with PS1 and/or PS2 endogenously (e.g. -catenin). 

Phrase: "Additionally,"

Phrase: "many of these presenilin-interacting proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439064:Many [Quantitative Concept]
   753   C0747726:many [Conceptual Entity]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "overexpression in cell systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "whereas"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205388:Few [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "and/or"

Phrase: "PS2 endogenously"

Phrase: "("

Phrase: "e.g. -catenin"

Phrase: ")."
Processing 00000000.tx.21: Although the N-terminal and loop domains are not conserved between the presenilins, FAD mutations have been identified within these regions in both proteins (1). 

Phrase: "Although"

Phrase: "the N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "loop domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conserved between the presenilins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "FAD mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "identified within these regions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "in both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: We have identified the protein sorcin as a PS2 loop-interacting molecule. 

Phrase: "We"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the protein sorcin as a PS2 loop-interacting molecule."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1420401:SORCIN [Gene or Genome]
Processing 00000000.tx.23: Sorcin is a penta-EF-hand Ca2+-binding protein that modulates the ryanodine receptor (RyR) intracellular calcium channel (39-43) and has previously been shown to be co-localize with brain RyR in the rat caudate-putamen nucleus (44). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "a penta-EF-hand Ca2+-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the ryanodine receptor (RyR) intracellular calcium channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0006726:Calcium [Inorganic Chemical]
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]
   804   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(39-43"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "co-localize with brain RyR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1419780:RYANODINE RECEPTOR, BRAIN [Gene or Genome]
   790   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1753335:ryanodine receptor [Molecular Function]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   753   C0392752:localize [Spatial Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in the rat caudate-putamen nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
   875   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   812   C0007610:Nucleus [Cell Component]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.24: We have found that sorcin interacts with the stable C-terminal endoproteolytic fragment of PS2 but not with the immature full-length form. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "interacts with the stable C-terminal endoproteolytic fragment of PS2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0205088:Terminal [Temporal Concept]
   739   C0205360:Stable [Qualitative Concept]
   739   C0332255:fragment [Functional Concept]
   739   C1547311:Stable [Intellectual Product]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not with the immature full-length form."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205252:Immature [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1518422:Not [Functional Concept]
   748   C1522492:Form [Functional Concept]
   748   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.25: This interaction between sorcin and a subset of the functional PS2 complexes was modulated by Ca2+ and occurred in a novel subcellular fraction. 

Phrase: "This interaction between sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "a subset of the functional PS2 complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "was"

Phrase: "modulated by Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443264:Modulated [Spatial Concept]
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "occurred in a novel subcellular fraction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0038528:Subcellular Fraction [Cell Component]
   753   C0205314:Novel [Temporal Concept]
   753   C0679622:novel [Intellectual Product]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.26: Our results reveal a molecular link between PS2 and intracellular Ca2+ channels, suggesting that sorcin is involved in the role of PS2 in intracellular Ca2+ homeostasis.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a molecular link between PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "intracellular Ca2+ channels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "involved in the role of PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1314939:Involved [Functional Concept]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in intracellular Ca2+ homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.27: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Expression Constructs-- Molecular cloning of cDNAs encoding sorcin (40) and grancalcin (45) from an adult human brain cDNA library was performed using a Marathon-ready rapid amplification of cDNA ends kit (CLONTECH). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "--"

Phrase: "Molecular cloning of cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "grancalcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423891:GRANCALCIN [Gene or Genome]

Phrase: "(45"

Phrase: ")"

Phrase: "from an adult human brain cDNA library"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0001675:Human, Adult [Age Group]
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0086418:Human [Human]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Marathon-ready rapid amplification of cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "ends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "kit (CLONTECH"

Phrase: ")."
Processing 00000000.tx.28: Isolated full-length cDNAs were subcloned into the pcDNA3.1/myc-His mammalian expression vector (Invitrogen), and the inserts were sequenced using a double-stranded DNA cycle sequencing system (Life Technologies, Inc.). 

Phrase: "Isolated full-length cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "subcloned into the pcDNA3.1/myc-"

Phrase: "His mammalian expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0813036:Inserts [Medical Device]
   966 E C0441587:Insert [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a double-stranded DNA cycle sequencing system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.29: Inducible expression constructs (pUHD10-3) coding for wild-type and N141I mutant versions of PS2 were previously described (32). 

Phrase: "Inducible expression constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "(pUHD10-3"

Phrase: ")"

Phrase: "coding for wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009219:Coding [Occupational Activity]

Phrase: "and"

Phrase: "N141I mutant versions of PS2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: "were"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.30: For the constitutive expression of PS2, the inserts from the inducible expression constructs (without FLAG epitope tags) were subcloned into pcDNA3.1/Zeo(+) (Invitrogen) and were fully verified by sequencing. 

Phrase: "For the constitutive expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of PS2,"

Phrase: "the inserts from the inducible expression constructs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0813036:Inserts [Medical Device]
   714 E C0441587:Insert [Health Care Activity]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "("

Phrase: "without FLAG epitope tags"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1139855:tags [Medical Device]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "subcloned into pcDNA3.1/Zeo"

Phrase: "(+"

Phrase: ")"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "fully"

Phrase: "verified by sequencing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]
Processing 00000000.tx.31: Generation of Stable PS2 Cell Lines-- Stable PS2 cell lines were generated by transfecting SH-SY5Y cells in a 100-mm dish with 5g of each plasmid: wild-type PS2, N141I PS2, or vector alone (pcDNA3.1/Zeo+). 

Phrase: "Generation of Stable PS2 Cell Lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "--"

Phrase: "Stable PS2 cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "generated by transfecting SH-SY5Y cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C3146294:Generated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in a 100-mm dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]

Phrase: "with 5g"

Phrase: "of each plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "wild-type PS2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "N141I PS2,"

Phrase: "or"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(pcDNA3.1/Zeo+"

Phrase: ")."
Processing 00000000.tx.32: Individual zeocin-resistant colonies were isolated and screened for PS2 expression by Western blotting using PS2Loop (30) and G2L (46). 

Phrase: "Individual zeocin-resistant colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439158:colonies [Quantitative Concept]
   779 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "screened for PS2 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop"

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "G2L"

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.33: Stable cell lines were maintained in the presence of 250g/ml Zeocin (Invitrogen) as described previously (32). 

Phrase: "Stable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C0598091:stable cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "maintained in the presence of 250g/ml Zeocin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0537913:Zeocin [Amino Acid, Peptide, or Protein]
   744   C1314677:Maintained [Functional Concept]
   711 E C0024501:Maintain [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.34: Antibodies, Western Blot Analyses, and Immunoprecipitation-- Protein quantitation, SDS-polyacrylamide gel electrophoresis (4-20 or 16%), and Western blotting were carried out as described previously (4, 56). 

Phrase: "Antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Western Blot Analyses,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "--"

Phrase: "Protein quantitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "(4-20"

Phrase: "or"

Phrase: "16%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(4,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.35: Primary antibodies were used at the following dilutions: PS2Loop (30) at 1:2500; 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used at the following dilutions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0079240:dilutions [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726   C0332283:follow [Temporal Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1947944:Use [Intellectual Product]
   726 E C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "PS2Loop"

Phrase: "(30"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "2500"

Phrase: ";"
Processing 00000000.tx.36: PS1Loop (30) at 1:3000; 

Phrase: "PS1Loop"

Phrase: "(30"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "3000"

Phrase: ";"
Processing 00000000.tx.37: monoclonal anti-sorcin (39) at 1:2000; 

Phrase: "monoclonal anti-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "(39"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.38: and polyclonal anti-sorcin (47) at 1:10,000. 

Phrase: "and"

Phrase: "polyclonal anti-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "(47"

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "10,000."
Processing 00000000.tx.39: To quantitate relative amounts of presenilin and sorcin in the blots, Fluor-S MultiImager and MultiAnalyst software (Bio-Rad) were utilized. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "relative amounts of presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "sorcin in the blots,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1420401:SORCIN [Gene or Genome]

Phrase: "Fluor-S MultiImager"

Phrase: "and"

Phrase: "MultiAnalyst software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Bio-Rad)"

Phrase: "were"

Phrase: "utilized."
Processing 00000000.tx.40: Cells or tissues were lysed using IP buffer (10mM Tris-HCl (pH 7.4), 150mM NaCl, 1% Triton X-100, 0.25% Nonidet P-40, 2mM EDTA) plus protease inhibitors, and solubilized proteins were subjected to immunoprecipitation. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IP buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10mM Tris-HCl (pH 7.4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "0.25% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "2mM EDTA) plus protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   804   C1947941:Protease [Enzyme]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "solubilized proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to immunoprecipitation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
Processing 00000000.tx.41: For the co-immunoprecipitation experiments, 0.25-0.5% Nonidet P-40 was utilized, and 0.1% bovine serum albumin was included. 

Phrase: "For the co-immunoprecipitation experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "0.25-0.5% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   795   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   795   C0439509:/40 [Temporal Concept]

Phrase: "was"

Phrase: "utilized"

Phrase: ","

Phrase: "and"

Phrase: "0.1% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.42: The samples were pre-cleared with protein A conjugated with magnetic beads (PerSeptive Diagnostics) for 1h at 4C, incubated with antibodies overnight, further incubated with protein A-magnetic beads (30l/sample) for 2h at 4C, and washed three times with IP buffer. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pre-cleared with protein A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332152:Pre [Temporal Concept]
   760   C0521097:cleared [Functional Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "conjugated with magnetic beads"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1328924:magnetic beads [Medical Device]
   770   C0024488:Magnetic [Occupation or Discipline]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0563532:magnetic [Natural Phenomenon or Process]
   770   C0991566:Beads [Biomedical or Dental Material]
   737 E C0301869:Conjugate [Immunologic Factor]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "(PerSeptive Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "incubated with antibodies overnight,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0439583:Overnight [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated with protein A-magnetic beads"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   790   C1328924:magnetic beads [Medical Device]
   753   C0024488:Magnetic [Occupation or Discipline]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0563532:magnetic [Natural Phenomenon or Process]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C2346972:Bead [Spatial Concept]

Phrase: "(30l/sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "washed three times with IP buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.43: Immunoprecipitates were collected using a magnetic bead collector, heated to 60C in sample buffer, and subjected to SDS-polyacrylamide gel electrophoresis and Western blotting. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a magnetic bead collector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0180011:collector [Medical Device]
   827   C1516695:Collector [Idea or Concept]
   734   C1328924:magnetic bead [Medical Device]

Phrase: "heated to 60C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "in sample buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "subjected to SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.44: Antibodies used include GM130 (Transduction Laboratories), calnexin (Stressgene), transferrin receptor (a gift of Dr. I.Trowbridge), APS26 (15) (a gift of Anke Diehlmann and Konrad Beyreuther), and calcineurin B (Santa Cruz Biotechnology). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "GM130"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415174:GM130 [Gene or Genome]

Phrase: "(Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "(Stressgene"

Phrase: ")"

Phrase: ","

Phrase: "transferrin receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "a gift of Dr. I.Trowbridge"

Phrase: ")"

Phrase: ","

Phrase: "APS26"

Phrase: "(15"

Phrase: ")"

Phrase: "("

Phrase: "a gift of Anke Diehlmann"

Phrase: "and"

Phrase: "Konrad Beyreuther"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "calcineurin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0255499:Calcineurin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149946:calcineurin [Molecular Function]

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.45: Confocal Microscopy-- Cells grown on glass coverslips or chamber slides were fixed (4% paraformaldehyde), double-stained with monoclonal anti-sorcin antibody and PS2loop, and then incubated with Cy3-conjugated anti-mouse secondary antibodies (Jackson Laboratories) and Bodipy-conjugated anti-rabbit secondary antibodies (Molecular Probes). 

Phrase: "Confocal Microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown on glass coverslips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]

Phrase: "or"

Phrase: "chamber slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0444330:slides [Research Device]
   827 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "(4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "-"

Phrase: "stained with monoclonal anti-sorcin antibody"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   753   C1420401:SORCIN [Gene or Genome]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "PS2loop,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with Cy3-conjugated anti-mouse secondary antibodies"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   767   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0027627:secondary [Neoplastic Process]
   744   C0175668:Secondary [Temporal Concept]
   744   C0205436:Secondary [Quantitative Concept]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Bodipy-conjugated anti-rabbit secondary antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   858   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   841 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   822   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0027627:secondary [Neoplastic Process]
   799   C0034493:Rabbit [Mammal]
   799   C0175668:Secondary [Temporal Concept]
   799   C0205436:Secondary [Quantitative Concept]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.46: Fluorescent images were captured and analyzed using a Bio-Rad 1024confocal microscope mounted on a Nikon inverted microscope. 

Phrase: "Fluorescent images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad 1024confocal microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]

Phrase: "mounted on a Nikon inverted microscope."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0181839:Microscope [Medical Device]
   753   C0443241:Inverted [Qualitative Concept]
   753   C0449878:mounted [Finding]
   753   C1706379:Microscope [Medical Device]
   719 E C0181909:Mount [Medical Device]
Processing 00000000.tx.47: Subcellular Fractionation-- Subcellular fractionation of cultured cells was performed using a protocol that has been previously described with minor modifications (48, 49). 

Phrase: "Subcellular Fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "Subcellular fractionation of cultured cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1656251:subcellular fractionation [Laboratory Procedure]
   781   C0007593:Cell Fractionation [Laboratory Procedure]
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described with minor modifications"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026193:Minor [Population Group]
   770   C0205165:Minor [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.48: Cells were washed twice each with ice-cold phosphate-buffered saline and homogenization buffer (10mM triethanolamine, 10mM acetic acid, 250mM sucrose, 1mM EDTA, and 1mM dithiothreitol) plus protease inhibitor mixture (Roche Molecular Biochemicals) and homogenized using a 25-gauge needle and a tight-pestle metal Dounce homogenizer. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "each with ice-cold phosphate-buffered saline"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1457900:Each [Quantitative Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "homogenization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10mM triethanolamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077089:triethanolamine [Organic Chemical,Pharmacologic Substance]

Phrase: "10mM acetic acid,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "250mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "plus protease inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "homogenized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 25-gauge needle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027551:Needle [Medical Device]
   827   C1704318:Needle [Medical Device]
   827   C1882041:Needle [Spatial Concept]
   734   C0456638:25 gauge [Quantitative Concept]

Phrase: "and"

Phrase: "a tight-pestle metal Dounce homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.49: A post-nuclear supernatant resulting from low speed centrifugation was separated by differential centrifugation at 1,000g, 14,000g, and 100,000g to yield post-nuclear supernatant, P2, and P3, respectively. 

Phrase: "A post-nuclear supernatant"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0521447:Nuclear [Spatial Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "resulting from low speed centrifugation"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0205251:low [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C0678536:Speed [Quantitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "was"

Phrase: "separated by differential centrifugation at 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0086972:Separated [Finding]
   753   C0443199:Differential [Qualitative Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1705242:Differential [Qualitative Concept]

Phrase: "000g,"

Phrase: "14,"

Phrase: "000g,"

Phrase: "and"

Phrase: "100,"

Phrase: "000g to"

Phrase: "yield"

Phrase: "post-nuclear supernatant,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0521447:Nuclear [Spatial Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "P3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.50: Pooled membrane fractions were further separated by density gradient centrifugation using step gradients consisting of 24,19.33,14.66,and 10% isotonic Nycodenz solutions (made in 0.75% NaCl, 10mM Tris (pH 7.4), 3mM KCl, and 1mM EDTA) and were fractionated using a density gradient fractionator. 

Phrase: "Pooled membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "separated by density gradient centrifugation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0178587:density [Quantitative Concept]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "step gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "consisting of 24,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "19.33,"

Phrase: "14.66,"

Phrase: "and"

Phrase: "10% isotonic Nycodenz solutions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0022260:Isotonic Solutions [Pharmacologic Substance]
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "("

Phrase: "made in 0.75% NaCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "10mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "3mM KCl,"

Phrase: "and"

Phrase: "1mM EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a density gradient fractionator."
Processing 00000000.tx.51: The fractions were then analyzed by Western blotting using antibodies to PS2, sorcin, and other marker proteins.  

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to PS2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "sorcin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "other marker proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.52: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Identification of Sorcin as an Interactor for the Large Hydrophilic Loop Region of PS2-- To search for putative interacting proteins for the PS2 loop region, we performed a domain-specific homology search of GenBankTM. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of Sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "as an Interactor"

Phrase: "for the Large Hydrophilic Loop Region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of PS2"

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "search for putative interacting proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]

Phrase: "for the PS2 loop region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a domain-specific homology search of GenBankTM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552603:search [Intellectual Product]
   748   C1706202:Search [Activity]
Processing 00000000.tx.53: The protein synexin was found to have a high degree of homology between its N terminus and a portion of the large hydrophilic loop region of PS2 (Fig. 1A). 

Phrase: "The protein synexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0103408:Synexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1412427:SYNEXIN [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a high degree of homology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "between its N terminus"

Phrase: "and"

Phrase: "a portion of the large hydrophilic loop region of PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449719:Portion [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.54: Synexin, also known as annexin VII, is a member of the annexin family of calcium- and phospholipid-binding proteins (50). 

Phrase: "Synexin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0103408:Synexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412427:SYNEXIN [Gene or Genome]

Phrase: "also"

Phrase: "known as annexin VII,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0103408:Annexin VII [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0162710:Annexin VII [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205309:Known [Qualitative Concept]
   770   C0445385:VII [Intellectual Product]

Phrase: "is"

Phrase: "a member of the annexin family of calcium-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "phospholipid-binding proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1148642:Phospholipid Binding [Molecular Function]
   871   C2929537:Phospholipids / Proteins [Pharmacologic Substance]
   827   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0202177:Phospholipid [Laboratory Procedure]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.55: We then asked whether the protein sorcin, which has previously been shown to interact with the N-terminal region of synexin (47), might also interact with the PS2 loop. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "asked"

Phrase: "whether"

Phrase: "the protein sorcin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "which"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the N-terminal region of synexin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0017446:Region [Geographic Area]
   744   C0103408:Synexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205147:Region [Spatial Concept]
   744   C1412427:SYNEXIN [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "might"

Phrase: "also"

Phrase: "interact with the PS2 loop."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.56: Sorcin is a member of the family of Ca2+-binding proteins harboring five EF-hand motifs (40, 41). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "a member of the family of Ca2+-binding proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "five EF-hand motifs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0752218:EF Hand Motifs [Spatial Concept]
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.57: We first isolated full-length sorcin cDNA from an adult human brain library and subcloned it into an expression plasmid encoding the Myc epitope tag; 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "full-length sorcin cDNA from an adult human brain library"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "it into an expression plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the Myc epitope tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.58: Myc-tagged sorcin (Myc-sorcin) was then stably transfected into human neuroblastoma SY5Y cells (Fig. 1B). 

Phrase: "Myc-tagged sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "(Myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "then stably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "transfected into human neuroblastoma SY5Y cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0427861:Human cells [Laboratory or Test Result]
   767   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0027819:Neuroblastoma [Neoplastic Process]
   753   C0086418:Human [Human]
   753   C0700095:neuroblastoma [Neoplastic Process]
   753   C3282337:Cells [Cell]
   753   C3540583:Neuroblastoma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: Western blot analysis using anti-Myc antibody revealed Myc-sorcin with an apparent molecular mass of 29kDa, and anti-sorcin antibodies detected a ~29-kDa transgene-derived epitope-tagged form of sorcin as well as the 26-kDa endogenous sorcin (Fig. 1B). 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "Myc-sorcin with an apparent molecular mass of 29kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "anti-sorcin antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a ~29-kDa transgene-derived epitope-tagged form of sorcin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "as well as"

Phrase: "the 26-kDa endogenous sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1420401:SORCIN [Gene or Genome]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: We next performed complementary co-immunoprecipitation analyses of PS2 and Myc-sorcin using PS2Loop antibody (30) in lysates prepared from COS cells transfected with either Myc-sorcin or a Myc-tagged control protein, Myc-grancalcin, or Myc-XIAP (Fig. 1C). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "complementary co-immunoprecipitation analyses of PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(30"

Phrase: ")"

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "prepared from COS cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with either Myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1420401:SORCIN [Gene or Genome]

Phrase: "or"

Phrase: "a Myc-tagged control protein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "Myc-grancalcin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1423891:GRANCALCIN [Gene or Genome]

Phrase: "or"

Phrase: "Myc-XIAP (Fig. 1C"

Phrase: ")."
Processing 00000000.tx.61: Only Myc-sorcin was co-immunoprecipitated by PS2Loop, indicating that Myc-sorcin interacts with endogenous PS2 C-terminal (loop) fragments (PS2-CTF) (Fig. 1C). 

Phrase: "Only Myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated by PS2Loop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "indicating"

Phrase: "that Myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "interacts with endogenous PS2 C-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205227:Endogenous [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "(loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: ")"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "(PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.62: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.63: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.64: Identification of sorcin as an interactor for the large hydrophilic loop region of PS2. 

Phrase: "Identification of sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "as an interactor"

Phrase: "for the large hydrophilic loop region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of PS2."
Processing 00000000.tx.65: A, homology between the large hydrophilic loop domain region of PS2 and the N-terminal region of synexin. 

Phrase: "A,"

Phrase: "homology between the large hydrophilic loop domain region of PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0314644:Homology region [Genetic Function]
   739   C1334043:Homology [Gene or Genome]
   739   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "the N-terminal region of synexin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.66: Amino acids 319-347 of human PS2 are compared with amino acids 17-56 of human synexin. 

Phrase: "Amino acids 319-347 of human PS2"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C0086418:Human [Human]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "compared with amino acids 17-56 of human synexin."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0086418:Human [Human]
   742   C0103408:Synexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1412427:SYNEXIN [Gene or Genome]
   742   C1707455:Compared [Activity]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.67: Identical residues are indicated by straight lines and similar residues are indicated by a +between the sequences. 

Phrase: "Identical residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "indicated by straight lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205132:lines [Spatial Concept]
   770   C0445291:Straight [Spatial Concept]
   770   C1444656:Indicated [Finding]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "similar residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "indicated by a +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]

Phrase: "between the sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.68: B, expression and detection of sorcin in stable sorcin cell lines. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "detection of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in stable sorcin cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.69: Human neuroblastoma SH-SY5Y cells were stably transfected with either empty vector (vector) or a Myc-tagged sorcin expression construct (myc-sorcin). 

Phrase: "Human neuroblastoma SH-SY5Y cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with either empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "(vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a Myc-tagged sorcin expression construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827421:Construct [Classification]

Phrase: "(myc-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.70: The cell lysates were analyzed by Western blot analyses using anti-Myc (left) or polyclonal anti-sorcin (right) antibodies. 

Phrase: "The cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed by Western blot analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0936012:Analyzed [Research Activity]
           Analysis
   760   C1705493:Western [Spatial Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Myc (left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "polyclonal anti-sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.71: C, identification of the interaction between sorcin and PS2 using co-immunoprecipitation of Myc-tagged sorcin and the endogenous PS2 C-terminal fragment (PS2-CTF). 

Phrase: "C,"

Phrase: "identification of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "between sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "co-immunoprecipitation of Myc-tagged sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   753   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "the endogenous PS2 C-terminal fragment (PS2-CTF)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragment [Functional Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.72: Detergent lysates from COS cells that were transiently transfected with the constructs indicated in the upper panel were immunoprecipitated (IP) with PS2loop and were analyzed by Western blotting using anti-Myc antibody. 

Phrase: "Detergent lysates from COS cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "that"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "indicated in the upper panel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441833:Panel [Idea or Concept]
   760   C1282910:Upper [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "were"

Phrase: "immunoprecipitated (IP) with PS2loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.73: Myc-tagged sorcin that co-immunoprecipitates with endogenous PS2-CTF is indicated by an arrow. 

Phrase: "Myc-tagged sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "that"

Phrase: "co-immunoprecipitates with endogenous PS2-CTF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0332255:fragment [Functional Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1708096:Fragment [Qualitative Concept]
   711   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "is"

Phrase: "indicated by an arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.74: D, detection of sorcin in human neuroblastoma cells and brain using combined immunoprecipitation-Western blot analyses. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "detection of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in human neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "combined immunoprecipitation-Western blot analyses."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   851   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   840   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   804   C1705493:Western [Spatial Concept]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
Processing 00000000.tx.75: Detergent lysates were prepared from cultured native SH-SY5Y cells (left) or human temporal cortex (right), and samples were subjected to immunoprecipitation with either pre-immune sera or polyclonal anti-sorcin antibodies and then analyzed by Western blotting with monoclonal anti-sorcin antibodies. 

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared from cultured native SH-SY5Y cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   774   C0007600:cultured cells [Cell]
   774   C0007635:Cultured Cells [Cell]
   774   C3282338:Cells, Cultured [Cell]
   748   C0007634:Cells [Cell]
   748   C0038108:SH [Geographic Area]
   748   C0302891:Native [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714   C1521827:Prepare [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "human temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0442043:Temporal [Spatial Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2362314:Temporal [Temporal Concept]
   827   C2700441:Cortex [Plant]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with either pre-immune sera"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0020960:Immune Sera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0229671:Sera [Body Substance]
   812   C1151254:SerA [Molecular Function]
   779 E C1546774:Serum [Intellectual Product]
   779 E C1550100:Serum [Body Substance]

Phrase: "or"

Phrase: "polyclonal anti-sorcin antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   886   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with monoclonal anti-sorcin antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.76: E, co-immunoprecipitation of sorcin and PS2-CTF in human brain extracts. 

Phrase: "E,"

Phrase: "co-immunoprecipitation of sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "PS2-CTF in human brain extracts."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0332255:fragment [Functional Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.77: Temporal cortex tissues from neurologically normal patients were homogenized, lysed in the presence of 0.5% Nonidet P-40, and subjected to immunoprecipitation using PS2Loop, with PS1Loop used as a control antibody. 

Phrase: "Temporal cortex tissues from neurologically normal patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0040300:Normal Tissue [Tissue]
           Tissues
   757   C0332441:Normal tissue [Finding]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "homogenized"

Phrase: ","

Phrase: "lysed in the presence of 0.5% Nonidet P-40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   760   C0444499:0/5 [Quantitative Concept]
   739   C0024348:lysed [Pathologic Function]
   739   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop,"

Phrase: "with PS1Loop"

Phrase: "used as a control antibody."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.78: Immunoprecipitates were then analyzed by Western blotting using polyclonal anti-sorcin antibody. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal anti-sorcin antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.79: Representative data from five independent experiments are shown. 

Phrase: "Representative data from five independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.80: Sorcin was detectable in human temporal cortex by combined immunoprecipitation-Western blotting analyses using two separate antibodies raised against human sorcin (Fig. 1D). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "was"

Phrase: "detectable in human temporal cortex"

Phrase: "by combined immunoprecipitation-Western blotting analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0949466:Western blot analysis [Laboratory Procedure]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two separate antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against human sorcin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C0442818:Raised [Quantitative Concept]
   770   C1420401:SORCIN [Gene or Genome]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.81: Sorcin in the human temporal cortex (~28 kDa) exhibited a slightly larger apparent molecular mass than sorcin in SH-SY5Y cells (~26 kDa), possibly due to alternative splicing; 

Phrase: "Sorcin in the human temporal cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1420401:SORCIN [Gene or Genome]

Phrase: "(~28 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a slightly larger apparent molecular mass than sorcin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   767   C0577559:A mass [Finding]
           Mass
   750   C1881358:Large Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]

Phrase: "in SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(~26 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "possibly due to alternative splicing"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0002345:Alternative Splicing [Genetic Function]
   806   C0678226:Due to [Functional Concept]
           due
   760   C0035687:Splicing [Genetic Function]
   760   C1523987:Alternative [Conceptual Entity]
   760   C2362652:Possibly [Qualitative Concept]
   760   C2610186:splicing [Genetic Function]
   760   C3146286:Due [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.82: a molecular mass of ~26-28 kDa is also slightly larger than the previously reported ~22 kDa (39, 40). 

Phrase: "a molecular mass of ~26-28 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1532717:kDa [Quantitative Concept]

Phrase: "is"

Phrase: "also slightly larger than the previously reported ~22 kDa (39,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0443228:larger [Quantitative Concept]
   739   C0549177:Larger [Quantitative Concept]
   739   C1704243:Larger [Quantitative Concept]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.83: To determine whether this endogenous sorcin associates with endogenous PS2 in vivo, detergent lysates were prepared from human temporal cortex and subjected to co-immunoprecipitation using PS2Loop antibody or with PS1Loop (30) as a negative control (Fig. 1E). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "this endogenous sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "associates with endogenous PS2 in vivo, detergent lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
   744   C0011740:Detergent [Chemical Viewed Functionally]
   744   C0205227:Endogenous [Functional Concept]
   744   C0750490:Associate [Idea or Concept]
   744   C1706221:Associate [Professional or Occupational Group]
   711   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared from human temporal cortex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0442043:Temporal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2362314:Temporal [Temporal Concept]
   760   C2700441:Cortex [Plant]
   726   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "subjected to co-immunoprecipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or with PS1Loop"

Phrase: "(30"

Phrase: ")"

Phrase: "as a negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1E"

Phrase: ")."
Processing 00000000.tx.84: Endogenous sorcin was recovered from these samples using only PS2Loop (Fig. 1E), indicating that sorcin associates with PS2 but not with PS1 in the brain. 

Phrase: "Endogenous sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "was"

Phrase: "recovered from these samples"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0521108:recovered [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737 E C2004454:recover [Organism Function]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only PS2Loop"

Phrase: "(Fig. 1E"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "associates with PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "not with PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C1518422:Not [Functional Concept]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.85: Subcellular Localization of the Sorcin-PS2 Molecular Complex-- To explore the cellular function of the PS2/sorcin interaction, we next attempted to determine the subcellular locus wherein the PS2/sorcin interaction occurs. 

Phrase: "Subcellular Localization of the Sorcin-PS2 Molecular Complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the cellular function of the PS2/sorcin interaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007613:Cellular Function [Cell Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the subcellular locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "wherein"

Phrase: "the PS2/sorcin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "occurs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.86: For this purpose, we first visualized sorcin and PS2-CTF in stable PS2-expressing SH-SY5Y cell lines using double immunofluorescence confocal microscopy (Fig. 2A). 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we first visualized sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "in stable PS2-expressing SH-SY5Y cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   883   C0598091:stable cell line [Cell]
   818   C0007600:Cell lines [Cell]
   795   C0007634:Cell [Cell]
   795   C0205132:lines [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "double immunofluorescence confocal microscopy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0242842:Microscopy, Confocal [Laboratory Procedure]
   812   C0026018:Microscopy [Laboratory Procedure]
   741 E C0205288:Microscopic [Qualitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.87: PS2 immunoreactivity was mainly detected in smooth ER/Golgi-like intracellular membrane compartments, whereas sorcin immunoreactivity was more disperse (Fig. 2A). 

Phrase: "PS2 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "mainly"

Phrase: "detected in smooth ER/Golgi-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0230789:smooth ER [Cell Component]
   760   C0018042:Golgi [Cell Component]
   760   C0205357:Smooth [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "like intracellular membrane compartments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]
   734   C0021868:Intracellular membrane [Cell Component]

Phrase: "whereas"

Phrase: "sorcin immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "more disperse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332624:Dispersion [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.88: Sorcin and PS2-CTF co-localized only to a restricted subcellular region (Fig. 2A, yellow indicates overlapping signals). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "co-localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]

Phrase: "only to a restricted subcellular region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0205171:Only [Quantitative Concept]
   753   C0443288:Restricted [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "(Fig. 2A,"

Phrase: "yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: "indicates"

Phrase: "overlapping signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.89: Since sorcin is a cytosolic protein (51) and PS2 is a known integral membrane protein (52), we predicted that a subset of cytosolic sorcin might associate with membranous subcellular structures to allow the interaction of sorcin with PS2. 

Phrase: "Since"

Phrase: "sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "a cytosolic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(51"

Phrase: ")"

Phrase: "and"

Phrase: "PS2"

Phrase: "is"

Phrase: "a known integral membrane protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0021699:Integral Membrane Protein [Amino Acid, Peptide, or Protein]
   861   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443238:Integral [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "a subset of cytosolic sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "might"

Phrase: "associate with membranous subcellular structures to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   773   C0041623:subcellular structure [Idea or Concept]
   773   C0729605:Subcellular structure [Cell Component]
   753   C0025255:Membranous [Tissue]
   753   C0205287:Membranous [Qualitative Concept]
   753   C0678594:structures [Spatial Concept]
   753   C0750490:Associate [Idea or Concept]
   753   C1706221:Associate [Professional or Occupational Group]
   742   C0682532:subcellular membrane [Cell Component]
   725   C0596901:membrane structure [Cell Component]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the interaction of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with PS2."
Processing 00000000.tx.90: To locate the PS2-sorcin interaction, we performed subcellular fractionation using stable PS2 SH-SY5Y cell lines. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "locate"

Phrase: "the PS2-sorcin interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "stable PS2 SH-SY5Y cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   887   C0598091:stable cell line [Cell]
   827   C0007600:Cell lines [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.91: After an initial homogenization and differential centrifugation, sorcin was predominantly found in the cytosolic fraction, although sorcin immunoreactivity was also detectable in the heavy membrane fraction, P2 (Fig. 2B). 

Phrase: "After an initial homogenization"

Phrase: "and"

Phrase: "differential centrifugation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007703:Centrifugation [Laboratory Procedure]
   861   C0443199:Differential [Qualitative Concept]
   861   C1705242:Differential [Qualitative Concept]

Phrase: "sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "was"

Phrase: "predominantly"

Phrase: "found in the cytosolic fraction,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1383501:Cytosolic [Cell Component]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0243095:Find [Finding]

Phrase: "although"

Phrase: "sorcin immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also detectable in the heavy membrane fraction,"

Phrase: "P2 (Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450354:2b [Intellectual Product]
   827   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.92: As predicted, PS2-CTF was absent in the cytosolic fraction and was highly enriched in the P2 fraction, where membrane-associated sorcin was detected (Fig. 2B). 

Phrase: "As"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: ","

Phrase: "PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "absent in the cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "enriched in the P2 fraction,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0359583:enriched [Food]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "where membrane-associated sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1420401:SORCIN [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.93: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.95: Subcellular localization of the sorcin-PS2 complex. 

Phrase: "Subcellular localization of the sorcin-PS2 complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.96: A, immunofluorescence confocal microscopy of sorcin and PS2. 

Phrase: "A,"

Phrase: "immunofluorescence confocal microscopy of sorcin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   797   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]

Phrase: "and"

Phrase: "PS2."
Processing 00000000.tx.97: Stable SY5Y cell lines expressing wild-type PS2 were fixed, permeabilized, and double-labeled with either monoclonal anti-sorcin antibody (red, Cy3) or PS2loop (green, Bodipy). 

Phrase: "Stable SY5Y cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: ","

Phrase: "permeabilized"

Phrase: ","

Phrase: "and"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "-"

Phrase: "labeled with either monoclonal anti-sorcin antibody"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]
   748   C1420401:SORCIN [Gene or Genome]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "Cy3"

Phrase: ")"

Phrase: "or"

Phrase: "PS2loop"

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "Bodipy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0381187:BODIPY [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.98: B, subcellular distribution of sorcin in cytosolic and membrane subcellular fractions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "subcellular distribution of sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "membrane subcellular fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0038528:Subcellular Fractions [Cell Component]
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.99: Wild-type PS2 stable SH-SY5Y cells were subjected to cell fractionation and differential centrifugation to yield post-nuclear supernatant (PNS), cytosol, and heavy (P2, 14,000g) and light (P3, 100,000g) membrane fractions. 

Phrase: "Wild-type PS2 stable SH-SY5Y cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   860   C0449475:type cell [Intellectual Product]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to cell fractionation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007593:Cell Fractionation [Laboratory Procedure]
   770   C0007634:Cell [Cell]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "differential centrifugation to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0443199:Differential [Qualitative Concept]
   827   C1705242:Differential [Qualitative Concept]

Phrase: "yield"

Phrase: "post-nuclear supernatant (PNS),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0521447:Nuclear [Spatial Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "(P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "14,"

Phrase: "000g"

Phrase: ")"

Phrase: "and"

Phrase: "light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "(P3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "100,"

Phrase: "000g"

Phrase: ")"

Phrase: "membrane fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.100: Equal amounts of protein from each subcellular fraction were analyzed by Western blotting using monoclonal anti-sorcin antibody or PS2Loop. 

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "from each subcellular fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038528:Subcellular Fraction [Cell Component]
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal anti-sorcin antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "PS2Loop."
Processing 00000000.tx.101: C, subcellular distribution of the sorcin-PS2 complex in density gradient subcellular fractions. 

Phrase: "C,"

Phrase: "subcellular distribution of the sorcin-PS2 complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in density gradient subcellular fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0038528:Subcellular Fractions [Cell Component]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.102: Total membrane fractions from stable SY5Y cells expressing wild-type PS2 were separated on a discontinuous Nycodenz gradient. 

Phrase: "Total membrane fractions from stable SY5Y cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0805525:Cell fractions [Cell Component]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "expressing"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "separated on a discontinuous Nycodenz gradient."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0086972:Separated [Finding]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0439599:Discontinuous [Temporal Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C0729204:Nycodenz [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1444662:Discontinuous [Finding]
Processing 00000000.tx.103: Fractions were collected from the top using a density gradient fractionator. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected from the top"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1704458:Top [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a density gradient fractionator."
Processing 00000000.tx.104: Equal volumes of each fraction were analyzed by Western blotting using PS2loop, monoclonal anti-sorcin antibody, anti-calcineurin B, and APS26 (anti-PS2 NTF, where NTF is N-terminal fragment) as well as antibodies to known subcellular organelle markers, including calnexin, GM130, and transferrin receptor (Tf-R). 

Phrase: "Equal volumes of each fraction"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C1264666:*Volume Fraction [Quantitative Concept]
   760   C0449468:volumes [Quantitative Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2loop,"

Phrase: "monoclonal anti-sorcin antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "anti-calcineurin B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0255499:Calcineurin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "APS26"

Phrase: "(anti-PS2 NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "where NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "as well as"

Phrase: "antibodies to known subcellular organelle markers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "calnexin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "GM130,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415174:GM130 [Gene or Genome]

Phrase: "and"

Phrase: "transferrin receptor (Tf-R)."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.105: Representative data from three independent experiments are presented. 

Phrase: "Representative data from three independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.106: To define the specific subcellular membrane compartment where the PS2/sorcin interaction occurs, total membrane fractions prepared from SH-SY5Y stably cells expressing wild-type PS2 were further separated using Nycodenz discontinuous density gradient centrifugation (48, 49). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the specific subcellular membrane compartment where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185625:Compartment [Body Space or Junction]
   804   C2986730:Compartment [Spatial Concept]

Phrase: "the PS2/sorcin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "total membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "prepared from SH-SY5Y stably cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1521827:Prepare [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Nycodenz discontinuous density gradient centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   804   C0007703:Centrifugation [Laboratory Procedure]
   804   C0178587:density [Quantitative Concept]
   804   C0439182:% gradient [Quantitative Concept]
   804   C0812409:Gradient [Quantitative Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.107: Each fraction was analyzed by Western blotting using antibodies to PS2 and sorcin (Fig. 2C). 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to PS2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.108: The full-length PS2 polypeptide exhibited virtually identical subcellular distribution to that of calnexin, a rough ER marker (arrow a, Fig. 2C). 

Phrase: "The full-length PS2 polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "virtually identical subcellular distribution to that of calnexin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "a rough ER marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005516:Marker [Clinical Attribute]
   734   C0230779:Rough ER [Cell Component]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "a,"

Phrase: "Fig. 2C"

Phrase: ")."
Processing 00000000.tx.109: In contrast, the PS2-CTF was visualized in three major peaks: peak one (fractions 3and 4), peak two (fractions 6-8), and peak three (fractions 11and 12) (Fig. 2C). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "visualized in three major peaks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205164:Major [Qualitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0234621:Visualized [Functional Concept]
   760   C0444505:peaks [Quantitative Concept]

Phrase: ":"

Phrase: "peak one (fractions 3and 4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0205447:One [Quantitative Concept]
   804   C0444505:Peak [Quantitative Concept]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "peak two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "(fractions 6-8"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "peak three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205449:Three [Quantitative Concept]
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(fractions 11and 12"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.110: Sorcin and PS2 were co-localized only to peak one membrane fractions, indicating that the PS2-sorcin complex was localized specifically to this subcellular compartment (arrow b, Fig. 2C). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "were"

Phrase: "co-localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]

Phrase: "only to peak one membrane fractions,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0205171:Only [Quantitative Concept]
   753   C0205447:One [Quantitative Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1706182:Membrane [Manufactured Object]
   753   C1720467:Only [Intellectual Product]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the PS2-sorcin complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "specifically to this subcellular compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(arrow b,"

Phrase: "Fig. 2C"

Phrase: ")."
Processing 00000000.tx.111: In addition, we performed Western blot analyses using antibodies to multiple subcellular marker proteins. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Western blot analyses"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to multiple subcellular marker proteins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   798   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.112: Interestingly, 19-kDa calcineurin B, a Ca2+-binding subunit of calcineurin, was distinctively co-distributed with sorcin in the Nycodenz gradient fractions (Fig. 2C). 

Phrase: "Interestingly,"

Phrase: "19-kDa calcineurin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0255499:Calcineurin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149946:calcineurin [Molecular Function]

Phrase: "a Ca2+-binding subunit of calcineurin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1149294:calcineurin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "distinctively"

Phrase: "co-distributed with sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1420401:SORCIN [Gene or Genome]
   770   C1704711:Distributed [Functional Concept]

Phrase: "in the Nycodenz gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.113: Membrane-associated sorcin did not appear to co-localize with the majority of other subcellular markers tested, including -adaptin, -adaptin, clathrin light chain, BAG-1, and Bcl-2 (data not shown). 

Phrase: "Membrane-associated sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0700364:APPEAR [Qualitative Concept]

Phrase: "co-localize with the majority of other subcellular markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0392752:localize [Spatial Concept]
   742   C0680220:majority [Social Behavior]
   708   C0005516:Marker [Clinical Attribute]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "adaptin, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1179085:Adaptin [Cell Component]

Phrase: "adaptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1179085:Adaptin [Cell Component]

Phrase: "clathrin light chain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1135987:Clathrin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0337112:Chain [Manufactured Object]
   827   C1306462:Light [Functional Concept]
   827   C1524075:Chain [Idea or Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "BAG-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179196:Bag [Manufactured Object]
   861   C1704776:Bag [Manufactured Object]

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: Neither the Golgi matrix protein GM130 nor the transferrin receptor co-distributed with sorcin or PS2 (Fig. 2C). 

Phrase: "Neither"

Phrase: "the Golgi matrix protein GM130"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415174:Golgi matrix protein GM130 [Gene or Genome]
           GM130
   708   C1423498:golgi protein [Gene or Genome]

Phrase: "nor"

Phrase: "the transferrin receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
  1000   C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-distributed with sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1420401:SORCIN [Gene or Genome]
   770   C1704711:Distributed [Functional Concept]

Phrase: "or"

Phrase: "PS2"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.115: These data demonstrate that membrane-associated sorcin and a subset of PS2 endoproteolytic fragments, but not full-length PS2, co-localize together to a subcellular compartment that is positive for calcineurin B.

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that membrane-associated sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420401:SORCIN [Gene or Genome]

Phrase: "and"

Phrase: "a subset of PS2 endoproteolytic fragments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "but"

Phrase: "not full-length PS2,"

Phrase: "co-localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localize [Spatial Concept]

Phrase: "together to a subcellular compartment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1185625:Compartment [Body Space or Junction]
   760   C1883357:Together [Qualitative Concept]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "positive for calcineurin B."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.116: Our data also indicate that the C-terminal endoproteolytic fragment and full-length forms of PS2 localize to different subcellular compartments in SH-SY5Y cells (Fig. 2C). 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the C-terminal endoproteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "forms of PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "localize to different subcellular compartments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392752:localize [Spatial Concept]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C1705242:Different [Qualitative Concept]
   726 E C2986730:Compartment [Spatial Concept]

Phrase: "in SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.117: Sorcin Associates with the PS2 Endoproteolytic C-terminal Fragment but Not with Full-length PS2-- To determine further the PS2 species that predominantly interacts with sorcin, we co-immunoprecipitated PS2 using anti-sorcin antibodies (Fig. 3A). 

Phrase: "Sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "Associates with the PS2 Endoproteolytic C-terminal Fragment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0332255:fragment [Functional Concept]
   744   C0750490:Associate [Idea or Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1706221:Associate [Professional or Occupational Group]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "Not with Full-length PS2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0443225:Full [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the PS2 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "that predominantly"

Phrase: "interacts with sorcin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1420401:SORCIN [Gene or Genome]

Phrase: "we"

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "PS2"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-sorcin antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.118: The levels of PS2-CTF that co-immunoprecipitated with endogenous sorcin were proportional to the levels of PS2-CTF detected in total cell lysates (data not shown). 

Phrase: "The levels of PS2-CTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "co-immunoprecipitated with endogenous sorcin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205227:Endogenous [Functional Concept]
   760   C1420401:SORCIN [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "proportional to the levels of PS2-CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205351:Proportional [Qualitative Concept]

Phrase: "detected in total cell lysates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1269647:Cell [Cell]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.119: Virtually no full-length PS2 was recovered in the sorcin immunoprecipitates, confirming that sorcin preferentially interacts with PS2-CTF (Fig. 3A). 

Phrase: "Virtually"

Phrase: "no full-length PS2"

Phrase: "was"

Phrase: "recovered in the sorcin immunoprecipitates,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0521108:recovered [Qualitative Concept]
   760   C1420401:SORCIN [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
   726 E C2004454:recover [Organism Function]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that sorcin preferentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "interacts with PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0332255:fragment [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.120: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.122: Interaction of sorcin with the C-terminal endoproteolytic fragment but not with full-length PS2. 

Phrase: "Interaction of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with the C-terminal endoproteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not with full-length PS2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0443225:Full [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.123: A, co-immunoprecipitation (Co-IP) of the PS2 CTF with endogenous sorcin using anti-sorcin antibody in stable SH-SY5Y cells. 

Phrase: "A,"

Phrase: "co-immunoprecipitation (Co-IP) of the PS2 CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   753   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with endogenous sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420401:SORCIN [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-sorcin antibody in stable SH-SY5Y cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.124: Detergent lysates from stable SH-SY5Y cells expressing vector (lane 1) or wild-type PS2 (lane 2) were immunoprecipitated (IP) with monoclonal anti-sorcin antibodies. 

Phrase: "Detergent lysates from stable SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "expressing"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "with monoclonal anti-sorcin antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.125: The PS2-CTF that co-immunoprecipitated with sorcin was detected by Western blotting using PS2Loop (top panel) or sorcin antibodies (bottom panel). 

Phrase: "The PS2-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "co-immunoprecipitated with sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1420401:SORCIN [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "was"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop"

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "sorcin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.126: The predicted location of full-length PS2 is indicated by an arrow (FL). 

Phrase: "The predicted location of full-length PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]

Phrase: "is"

Phrase: "indicated by an arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]

Phrase: "(FL)."
Processing 00000000.tx.127: Other immunoreactivities in the gel derive from mouse IgG light and heavy chains (*). 

Phrase: "Other immunoreactivities in the gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0597879:immunoreactivity [Molecular Function]

Phrase: "derive from mouse IgG light"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1306462:Light [Functional Concept]
   760   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "heavy chains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1420192:heavy chain [Gene or Genome]
   861   C0337112:chains [Manufactured Object]
   861   C0439539:Heavy [Qualitative Concept]
   861   C1524075:Chains [Idea or Concept]

Phrase: "("

Phrase: "*"

Phrase: ")."
Processing 00000000.tx.128: B, accumulation of the full-length and high molecular forms of PS2 induced by treatment with proteasome inhibitors fails to enhance the interaction between PS2 and sorcin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "accumulation of the full-length"

Phrase: "and"

Phrase: "high molecular forms of PS2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "induced by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0205263:Induced [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the interaction between PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "sorcin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]
Processing 00000000.tx.129: Stable SH-SY5Y cell lines expressing wild-type PS2 were incubated for 6h with Me2SO (lanes 1,4,and 7) or proteasome inhibitors ALLN (lanes 2,5,and 8) or MG132 (lanes 3,6,and 9). 

Phrase: "Stable SH-SY5Y cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   894   C0598091:stable cell line [Cell]
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "incubated for 6h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292428:6H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with Me2SO"

Phrase: "(lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "4,"

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "or"

Phrase: "proteasome inhibitors ALLN"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   734   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitors [Molecular Function]
   701 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "(lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "or"

Phrase: "MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(lanes 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "6,"

Phrase: "and"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.130: Detergent lysates were subjected to co-immunoprecipitation using PS2loop. 

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to co-immunoprecipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2loop."
Processing 00000000.tx.131: Immunoprecipitates along with straight cell lysates (20g each; lanes 7-9) were analyzed by Western blot analyses using the antibodies indicated in the bottom panels. 

Phrase: "Immunoprecipitates along with straight cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate
   753   C0007634:Cell [Cell]
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C0445291:Straight [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(20g"

Phrase: "each"

Phrase: "; lanes 7-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western blot analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0936012:Analyzed [Research Activity]
           Analysis
   760   C1705493:Western [Spatial Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicated in the bottom panels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Panel [Idea or Concept]
   760   C1444656:Indicated [Finding]
   760   C1511276:Bottom [Spatial Concept]
   760   C1552825:bottom [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.132: The locations of full-length PS2 and the normal and alternative PS2 C-terminal fragments are indicated by arrows. 

Phrase: "The locations of full-length PS2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0450429:locations [Spatial Concept]
   719 E C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "alternative PS2 C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.133: We next tested whether increased accumulation of full-length PS2 affects the interaction between sorcin and PS2. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "increased accumulation of full-length PS2"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the interaction between sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PS2."
Processing 00000000.tx.134: Both treatment with the proteasome inhibitors MG132 or ALLN (Fig. 3B) and overexpression of PS2 by transient transfection (data not shown) have previously been shown to lead to increased levels of full-length PS2 and ubiquitin-positive high molecular weight forms of PS2 but not PS2 endoproteolytic fragments (32, 53). 

Phrase: "Both treatment with the proteasome inhibitors MG132"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "ALLN"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "overexpression of PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "by transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to increased levels of full-length PS2"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   789   C1318746:increased lead levels [Finding]
   767   C0428255:lead levels [Laboratory or Test Result]
   767   C0861064:increased lead [Finding]
   750 E C0524167:Lead level [Laboratory Procedure]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0443225:Full [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1444754:Length [Quantitative Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ubiquitin-positive high molecular weight"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C1979900:High molecular weight [Qualitative Concept]
   853   C0948775:high weight [Sign or Symptom]
   840   C0026385:Molecular Weight [Quantitative Concept]
   804   C0005910:weight [Organism Attribute]
   804   C0043100:Weight [Quantitative Concept]
   804   C0205250:High [Qualitative Concept]
   804   C1299351:High [Qualitative Concept]
   804   C1305866:weight [Diagnostic Procedure]
   804   C1521991:Molecular [Qualitative Concept]
   804   C1705104:Weight [Idea or Concept]
   804   C2700149:HIGH [Intellectual Product]
   733 E C0567416:Molecule [Substance]

Phrase: "forms of PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "not PS2 endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "(32,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.135: No increase was observed in the interaction between PS2 and sorcin under either condition. 

Phrase: "No increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed in the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441672:Observed [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "between PS2"

Phrase: "and"

Phrase: "sorcin under either condition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1420401:SORCIN [Gene or Genome]
Processing 00000000.tx.136: Along with the subcellular fractionation data, our studies reveal that sorcin interacts with a subset of the PS2 complexes consisting of the endoproteolytic fragments but does not interact with full-length PS2. 

Phrase: "Along with the subcellular fractionation data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C1656251:subcellular fractionation [Laboratory Procedure]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "interacts with a subset of the PS2 complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C1515021:Subset [Classification]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "consisting of the endoproteolytic fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with full-length PS2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443225:Full [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.137: Elevated Intracellular Calcium Enhances the Sorcin/PS2 Interaction and Translocation of Sorcin to the Membrane-- We next examined whether increasing the cytosolic Ca2+ concentration modulates the sorcin/PS2 interaction. 

Phrase: "Elevated Intracellular Calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "Enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the Sorcin/PS2 Interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Translocation of Sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]

Phrase: "to the Membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the cytosolic Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the sorcin/PS2 interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.138: Treatment with the Ca2+ ionophore A23187 did not alter the steady-state levels of sorcin or PS2 (Fig. 4A). 

Phrase: "Treatment with the Ca2+ ionophore A23187"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the steady-state levels of sorcin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "PS2"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.139: Meanwhile, the level of sorcin that co-immunoprecipitated with PS2Loop greatly increased as the result of A23187 treatment (Fig. 4A). 

Phrase: "Meanwhile,"

Phrase: "the level of sorcin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "co-immunoprecipitated with PS2Loop greatly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "increased as the result of A23187 treatment"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0878412:A23187 [Antibiotic,Organic Chemical]
   748   C1274040:Result [Functional Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1546471:Result [Idea or Concept]
   748   C1705169:Treatment [Conceptual Entity]
   748   C2825142:Result [Finding]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.140: To explore the possibility that Ca2+ mediates the translocation of the sorcin-PS2 complex, we examined the subcellular distribution of membrane-associated sorcin in PS2-expressing cells that were grown in the presence or absence of A23187. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the possibility"

Phrase: "that Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the translocation of the sorcin-PS2 complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C2987521:Translocation [Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the subcellular distribution of membrane-associated sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in PS2-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "grown in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of A23187."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.141: Although A23187 did not alter the subcellular distribution of the sorcin-PS2 complex, we found that A23187 treatment led to increased association of sorcin with the membrane (Fig. 4B). 

Phrase: "Although"

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the subcellular distribution of the sorcin-PS2 complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that A23187 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "led to increased association of sorcin"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   767   C0861064:increased lead [Finding]
   753   C0004083:Association [Mental Process]
   753   C0205217:Increased [Quantitative Concept]
   753   C0439849:Association [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   753   C1420401:SORCIN [Gene or Genome]
   753   C1708698:LED [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: Our studies demonstrate that sorcin is translocated from the cytosol to the membrane when cytosolic Ca2+ is elevated by this ionophore, indicating that the recruitment of sorcin into a molecular complex harboring PS2 is modulated by intracellular Ca2+ levels. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "translocated from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "to the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "when"

Phrase: "cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "elevated by this ionophore,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022022:Ionophore [Pharmacologic Substance]
   770   C0205250:Elevated [Qualitative Concept]
   770   C1517596:ionophore [Molecular Function]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the recruitment of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "into a molecular complex harboring PS2"

Phrase: "is"

Phrase: "modulated by intracellular Ca2+ levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0443264:Modulated [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.143: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 4.  

Phrase: "4."
Processing 00000000.tx.145: Elevated intracellular calcium enhances the association of sorcin with PS2 and the recruitment of sorcin to the membrane. 

Phrase: "Elevated intracellular calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the association of sorcin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with PS2"

Phrase: "and"

Phrase: "the recruitment of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "to the membrane."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.146: A, treatment with the calcium ionophore A23187 increases the binding between sorcin and PS2. 

Phrase: "A,"

Phrase: "treatment with the calcium ionophore A23187"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the binding between sorcin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "PS2."
Processing 00000000.tx.147: SY5Y cells stably expressing wild-type PS2 were grown in the presence of Me2SO (lanes 1and 3) or 20M A23187 for 3h, and detergent lysates were subjected to co-immunoprecipitation using PS2loop. 

Phrase: "SY5Y cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "grown in the presence of Me2SO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "20M A23187 for 3h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to co-immunoprecipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2loop."
Processing 00000000.tx.148: The amount of sorcin that co-immunoprecipitated with PS2-CTF was greatly enhanced by treatment with A23187, whereas the total amount of sorcin in the lysates remained unchanged. 

Phrase: "The amount of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "co-immunoprecipitated with PS2-CTF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragment [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "was"

Phrase: "greatly"

Phrase: "enhanced by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C2349975:Enhanced [Activity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "whereas"

Phrase: "the total amount of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "remained"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.149: B, A23187 treatment increases the association of sorcin with membrane fractions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "A23187 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the association of sorcin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with membrane fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.150: Stable PS2 SY5Y cells were grown in the above-mentioned conditions and were subjected to subcellular fractionation as described in Fig. 

Phrase: "Stable PS2 SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in the above-mentioned conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "were"

Phrase: "subjected to subcellular fractionation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.151: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.152: Equal volumes of each fraction were analyzed by Western blot analyses using sorcin antibodies, and sorcin immunoreactivities were normalized to the unit membrane protein in the subcellular fractions and plotted.  

Phrase: "Equal volumes of each fraction"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C1264666:*Volume Fraction [Quantitative Concept]
   760   C0449468:volumes [Quantitative Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed by Western blot analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0936012:Analyzed [Research Activity]
           Analysis
   760   C1705493:Western [Spatial Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sorcin antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "sorcin immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "were"

Phrase: "normalized to the unit membrane protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1706058:Protein Unit [Quantitative Concept]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439148:Unit [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1706182:Membrane [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]
   753   C1882115:Normalized [Research Activity]

Phrase: "in the subcellular fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0038528:Subcellular Fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "plotted."
Processing 00000000.tx.153: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES We report that presenilin 2interacts endogenously with sorcin, a modulator of the RyR intracellular Ca2+-releasing channel. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that presenilin 2interacts endogenously with sorcin,"

Phrase: "a modulator of the RyR intracellular Ca2+-releasing channel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709060:Modulator [Manufactured Object]
Processing 00000000.tx.154: Regulation of ryanodine receptor activity by accessory molecules has been implicated in synaptic plasticity and other neuronal activities (43, 54-56). 

Phrase: "Regulation of ryanodine receptor activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   891   C2265601:regulation of receptor activity [Physiologic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by accessory molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in synaptic plasticity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "other neuronal activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "(43,"

Phrase: "54-56"

Phrase: ")."
Processing 00000000.tx.155: We have also shown that membrane-bound forms of sorcin co-fractionate with a subset of PS2 endoproteolytic fragments to a subcellular compartment harboring calcineurin B (Fig. 2C), another Ca2+-binding molecule that appears to be involved in the regulation of both inositol 1,4,5-trisphosphate- and ryanodine-sensitive intracellular Ca2+ channels (57). 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that membrane-bound forms of sorcin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "co-fractionate with a subset of PS2 endoproteolytic fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C1515021:Subset [Classification]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "to a subcellular compartment harboring calcineurin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0255499:Calcineurin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1149946:calcineurin [Molecular Function]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ","

Phrase: "another Ca2+-binding molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the regulation of both inositol 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]

Phrase: "4,"

Phrase: "5-trisphosphate-"

Phrase: "and"

Phrase: "ryanodine-sensitive intracellular Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.156: In addition, the PS2-sorcin interaction and the translocation of sorcin to the membrane appear to be increased by elevated intracellular Ca2+ levels (Fig. 4). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the PS2-sorcin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the translocation of sorcin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]

Phrase: "to the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased by elevated intracellular Ca2+ levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C3163633:Elevated [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: These data reveal a molecular link between PS2 and cellular Ca2+ channels and raise the possibility that sorcin is recruited by PS2 into a molecular complex involved in intracellular Ca2+ modulation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a molecular link between PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "cellular Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "is"

Phrase: "recruited by PS2"

Phrase: "into a molecular complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "involved in intracellular Ca2+ modulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0443264:Modulation [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1314939:Involved [Functional Concept]
Processing 00000000.tx.158: In the future, it will be important to characterize the membranous organelles harboring the PS2-sorcin complex and to determine whether the PS2-sorcin complex includes an intracellular Ca2+ channel (e.g. RyR) as a primary component. 

Phrase: "In the future,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "characterize"

Phrase: "the membranous organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the PS2-sorcin complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the PS2-sorcin complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "an intracellular Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "("

Phrase: "e.g. RyR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "as a primary component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.159: Although other Ca2+-binding proteins have been shown to interact with PS2, such as calsenilin and calmyrin (26, 27), these interactions were demonstrated only in cells transiently transfected with PS2 cDNAs (26, 27). 

Phrase: "Although"

Phrase: "other Ca2+-binding proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with PS2,"

Phrase: "such as calsenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0758551:Calsenilin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1825644:CALSENILIN [Gene or Genome]

Phrase: "and"

Phrase: "calmyrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424635:CALMYRIN [Gene or Genome]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "demonstrated"

Phrase: "only in cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS2 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.160: We (Fig. 3 and Ref. 53) and others (30) have demonstrated that overexpression of PS2 leads to an accumulation of full-length PS2, whereas levels of PS2 fragments are reduced or unchanged. 

Phrase: "We (Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Ref. 53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that overexpression of PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "leads to an accumulation of full-length PS2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0443225:Full [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1444754:Length [Quantitative Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "levels of PS2 fragments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "or"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.161: Accordingly, the PS2 species that were found to interact detectably with calsenilin and calmyrin were full-length PS2 but not PS2 endoproteolytic fragments (26, 27). 

Phrase: "Accordingly,"

Phrase: "the PS2 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact"

Phrase: "detectably with calsenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0758551:Calsenilin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1825644:CALSENILIN [Gene or Genome]

Phrase: "and"

Phrase: "calmyrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424635:CALMYRIN [Gene or Genome]

Phrase: "were"

Phrase: "full-length PS2"

Phrase: "but"

Phrase: "not PS2 endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.162: Because growing evidence indicates that the endoproteolytic fragments comprise the functional units of the presenilins (11, 30), rather than the full-length proteins, calsenilin and calmyrin most likely play a role in the proteolysis, trafficking, or stabilization of full-length PS2 intermediates. 

Phrase: "Because"

Phrase: "growing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the functional units of the presenilins"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "(11,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "rather than"

Phrase: "the full-length proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "calsenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0758551:Calsenilin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1825644:CALSENILIN [Gene or Genome]

Phrase: "and"

Phrase: "calmyrin most likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1424635:CALMYRIN [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the proteolysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: ","

Phrase: "or"

Phrase: "stabilization of full-length PS2 intermediates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.163: In contrast, our data show that sorcin interacts with a subset of PS2 endoproteolytic fragments but not with full-length PS2, further supporting the possibility that the sorcin-PS2 interaction has a functional role (i.e. in Ca2+ modulation). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420401:SORCIN [Gene or Genome]

Phrase: "interacts with a subset of PS2 endoproteolytic fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1515021:Subset [Classification]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not with full-length PS2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0443225:Full [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the sorcin-PS2 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "has"

Phrase: "a functional role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1705810:Functional Role [Conceptual Entity]
           Role
   861   C0035820:Role [Social Behavior]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in Ca2+ modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443264:Modulation [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.164: Implications of the sorcin-PS2 interaction for FAD remain to be elucidated. 

Phrase: "Implications of the sorcin-PS2 interaction"

Phrase: "for FAD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.165: Since the large hydrophilic loop regions are divergent between PS1 and PS2 and no FAD mutation has been identified in the putative sorcin binding region of PS2 (synexin homologous domain), the exact contributions of sorcin and other PS1/PS2 loop-interacting molecules to AD neuropathogenesis have not been fully elucidated (16-19, 58). 

Phrase: "Since"

Phrase: "the large hydrophilic loop regions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "divergent between PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0443204:Divergence [Spatial Concept]

Phrase: "and"

Phrase: "PS2"

Phrase: "and"

Phrase: "no FAD mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "identified in the putative sorcin binding region of PS2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C0205396:Identified [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1420401:SORCIN [Gene or Genome]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]

Phrase: "(synexin homologous domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the exact contributions of sorcin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "other PS1/PS2 loop-interacting molecules to AD neuropathogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0567416:molecules [Substance]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "elucidated"

Phrase: "(16-19,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.166: Interestingly, increased amyloid -peptide levels can result from RyR-driven elevations in intracellular Ca2+ (59). 

Phrase: "Interestingly,"

Phrase: "increased amyloid -peptide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "result from RyR-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1753335:ryanodine receptor [Molecular Function]
   770   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "elevations in intracellular Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0702240:elevations [Spatial Concept]
   737 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.167: On the other hand, decreased RyR activity correlates with early pathological changes in AD (60). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "decreased RyR activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1753335:ryanodine receptor activity [Molecular Function]
   902   C0086439:Decreased activity [Sign or Symptom]
   861   C1152633:receptor activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "correlates with early pathological changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1521733:Pathological [Functional Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in AD (60"

Phrase: ")."
Processing 00000000.tx.168: To this end, we are currently investigating whether the sorcin/PS2 interaction is involved in either Ca2+-related increases in amyloid -peptide or observed defects in RyR activity in AD. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "whether"

Phrase: "the sorcin/PS2 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "involved in either Ca2+-related increases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439849:Related [Qualitative Concept]
   753   C0442805:increases [Functional Concept]
   753   C0445223:Related [Finding]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1314939:Involved [Functional Concept]

Phrase: "in amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "observed defects in RyR activity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0243067:defects [Functional Concept]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in AD."
Processing 00000000.tx.169: In any event, our study implies that the sorcin/PS2 interaction may play a normal and/or pathological role in intracellular Ca2+ homeostasis.  

Phrase: "In any event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "implies"

Phrase: "that"

Phrase: "the sorcin/PS2 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and/or"

Phrase: "pathological role in intracellular Ca2+ homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.170: ACKNOWLEDGEMENTS We thank L.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.171: Kanaley-Andrews and E.Bird at the Harvard Brain Tissue Resources Center for postmortem brain tissues; 

Phrase: "Kanaley-Andrews"

Phrase: "and"

Phrase: "E.Bird at the Harvard Brain Tissue Resources"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0005595:Bird [Bird]

Phrase: "Center for postmortem brain tissues"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0440746:brain tissues [Tissue]
   781   C0444184:Postmortem tissue [Tissue]
   773 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   760   C0004398:postmortem [Diagnostic Procedure]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0040300:Tissues [Tissue]
   760   C0205099:Center [Spatial Concept]
   760   C0580205:Postmortem [Temporal Concept]
   760   C0848632:post mortem [Finding]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.172: M.Kim for helpful discussions; 

Phrase: "M."

Phrase: "Kim for helpful discussions"

Phrase: ";"
Processing 00000000.tx.173: T.Z.

Phrase: "T.Z."
Processing 00000000.tx.174: Grenfell and A.J.

Phrase: "Grenfell"

Phrase: "and"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.175: Saunders for critical review of the manuscript; 

Phrase: "Saunders for critical review of the manuscript"

Phrase: ";"
Processing 00000000.tx.176: and G.

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.177: Thinakaran, S.

Phrase: "Thinakaran,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.178: Sisodia, T.Tomita, T.

Phrase: "Sisodia,"

Phrase: "T.Tomita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.179: Iwatsubo, A.

Phrase: "Iwatsubo,"

Phrase: "A."
Processing 00000000.tx.180: Diehlmann, K.

Phrase: "Diehlmann,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.181: Beyreuther, and I.

Phrase: "Beyreuther,"

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.182: Trowbridge for antibodies.  

Phrase: "Trowbridge for antibodies."
Processing 00000000.tx.183: FOOTNOTES * This work was supported in part by NIA grants from the National Institutes of Health and the Alzheimer's Association.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by NIA grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018173:Grants [Quantitative Concept]
   827 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "the Alzheimer's Association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.184: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.185: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.186: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.187: Kenner Fellow of the American Heart Association. 

Phrase: "Kenner Fellow of the American Heart Association."
Processing 00000000.tx.188: ** Howard Hughes Medical Institute Medical Student Training Fellow. 

Phrase: "*"

Phrase: "* Howard Hughes Medical Institute Medical Student Training Fellow."
Processing 00000000.tx.189: Recipient of the Partners Investigator (Nesson) award. 

Phrase: "Recipient of the Partners Investigator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "(Nesson"

Phrase: ")"

Phrase: "award."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004446:Award [Manufactured Object]
Processing 00000000.tx.190: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.191: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.192: 617-726-3739; 

Phrase: "617-726-3739"

Phrase: ";"
Processing 00000000.tx.193: Fax: 617-726-5677; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-726-5677"

Phrase: ";"
Processing 00000000.tx.194: E-mail: kim@helix.mgh.harvard.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kim@helix.mgh.harvard.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.195: Published, JBC Papers in Press, March 15,2000,DOI 10.1074/jbc.M909882199  ABBREVIATIONS The abbreviations used are: FAD, familial Alzheimer's disease; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "March 15,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M909882199  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.196: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.197: CTF, C-terminal fragment; 

Phrase: "CTF,"

Phrase: "C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.198: PS1, presenilin 1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.199: PS2, presenilin 2; 

Phrase: "PS2,"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.200: RyR, ryanodine receptor.  

Phrase: "RyR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "ryanodine receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.201: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.202: Tanzi, R. 

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.203: E., Kovacs, D. 

Phrase: "E.,"

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.204: M., Kim, T.-W., Moir, R. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "T.-W., Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.205: D., Guenette, S. 

Phrase: "D."

Phrase: ","

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.206: Y., and Wasco, W. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.207: (1996) Neurobiol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.208: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.209: 3, 159-168[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "159-168"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.210: De Strooper, B., Saftig, P., Craessaerts, K., Vandersticheles, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vandersticheles,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.211: (1998) Nature 391, 387-390[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 391,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "387-390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.212: Steiner, H., Duff, K., Capell, A., Romig, H., Grim, M. 

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.213: G., Lincoln, S., Hardy, J., Yu, X., Picciano, M., Fechteler, K., Citron, M., Kopan, R., Pesold, B., Keck, S., Baader, M., Tomita, T., Iwatsubo, T., Baumeister, R., and Haass, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Picciano,"

Phrase: "M."

Phrase: ","

Phrase: "Fechteler,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Kopan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Keck,"

Phrase: "S."

Phrase: ","

Phrase: "Baader,"

Phrase: "M."

Phrase: ","

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Baumeister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.214: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.215: Biol. 

Phrase: "Biol."
Processing 00000000.tx.216: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.217: 274, 28669-28673[Abstract/Free FullText] 4. 

Phrase: "274,"

Phrase: "28669-28673"

Phrase: "[Abstract/Free FullText"

Phrase: "] 4."
Processing 00000000.tx.218: Wolfe, M. 

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.219: S., Xia, W., Ostaszewski, B. 

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.220: L., Diehl, T. 

Phrase: "L., Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.221: S., Kimberly, W. 

Phrase: "S."

Phrase: ","

Phrase: "Kimberly,"

Phrase: "W."
Processing 00000000.tx.222: T., and Selkoe, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.223: J. 

Phrase: "J."
Processing 00000000.tx.224: (1999) Nature 398, 513-517[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "513-517"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.225: De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J., Schroeter, E. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mumm,"

Phrase: "J.,"

Phrase: "Schroeter,"

Phrase: "E."
Processing 00000000.tx.226: H., Schrijvers, V., Wolfe, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schrijvers,"

Phrase: "V.,"

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.227: S., Ray, W. 

Phrase: "S."

Phrase: ","

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W."
Processing 00000000.tx.228: J., Goate, A., and Kopan, R. 

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.229: (1999) Nature 398, 518-222[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "518-222"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.230: Struhl, G., and Greenwald, I. 

Phrase: "Struhl,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.231: (1999) Nature 398, 522-525[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "522-525"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.232: Ye, Y., Lukinova, N., and Fortini, M. 

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Y.,"

Phrase: "Lukinova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Fortini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.233: E. 

Phrase: "E."
Processing 00000000.tx.234: (1999) Nature 398, 525-529[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "525-529"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.235: Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. 

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J.-J.,"

Phrase: "Kusiak,"

Phrase: "J."
Processing 00000000.tx.236: W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D. 

Phrase: "W., Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qian,"

Phrase: "X.,"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.237: D., Price, D. 

Phrase: "D."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.238: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.239: R., Wong, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wong,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.240: C., and Sisodia, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.241: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.242: (1998) Neuron 21, 1213-1221[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 21,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1213-1221"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.243: Hardy, J. 

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.244: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.245: 20, 154-159[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "20,"

Phrase: "154-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.246: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.247: J. 

Phrase: "J."
Processing 00000000.tx.248: (1998) Trends Cell Biol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.249: 8, 447-453[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "8,"

Phrase: "447-453"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.250: Thinakaran, G. 

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.251: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.252: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.253: Invest. 

Phrase: "Invest."
Processing 00000000.tx.254: 104, 1321-1327[Free FullText] 12. 

Phrase: "104,"

Phrase: "1321-1327"

Phrase: "[Free FullText"

Phrase: "] 12."
Processing 00000000.tx.255: Guo, Q., Furukawa, K., Sopher, B. 

Phrase: "Guo,"

Phrase: "Q.,"

Phrase: "Furukawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sopher,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.256: L., Pham, D. 

Phrase: "L., Pham,"

Phrase: "D."
Processing 00000000.tx.257: G., Xie, J., Robinson, N., Martin, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Xie,"

Phrase: "J.,"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.258: M., and Mattson, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.259: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.260: (1996) Neuroreport 8, 379-383[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuroreport 8,"

Phrase: "379-383"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.261: Leissring, M. 

Phrase: "Leissring,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: A., Parker, I., and LaFerla, F. 

Phrase: "A.,"

Phrase: "Parker,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.263: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.264: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.265: Biol. 

Phrase: "Biol."
Processing 00000000.tx.266: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.267: 274, 32535-32538[Abstract/Free FullText] 14. 

Phrase: "274,"

Phrase: "32535-32538"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.268: Zhou, J., Liyanage, U., Medina, M., Ho, C., Simmons, A. 

Phrase: "Zhou,"

Phrase: "J.,"

Phrase: "Liyanage,"

Phrase: "U.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Simmons,"

Phrase: "A."
Processing 00000000.tx.269: D., Lovett, M., and Kosik, K. 

Phrase: "D."

Phrase: ","

Phrase: "Lovett,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.270: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.271: (1997) Neuroreport 8, 2085-2090[Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroreport 8,"

Phrase: "2085-2090"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.272: Tesco, G., Kim, T.-W., Diehlmann, A., Beyreuther, K., and Tanzi, R. 

Phrase: "Tesco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "T.-W., Diehlmann,"

Phrase: "A.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.273: E. 

Phrase: "E."
Processing 00000000.tx.274: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.275: Biol. 

Phrase: "Biol."
Processing 00000000.tx.276: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.277: 273, 33909-33914[Abstract/Free FullText] 16. 

Phrase: "273,"

Phrase: "33909-33914"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.278: Zhang, Z., Hartmann, H., Do, V. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Hartmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Do"

Phrase: ","

Phrase: "V."
Processing 00000000.tx.279: M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., De Strooper, B., He, X., and Yankner, B. 

Phrase: "M."

Phrase: ","

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van de Wetering,"

Phrase: "M."

Phrase: ","

Phrase: "Clevers,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "He,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.280: A. 

Phrase: "A."
Processing 00000000.tx.281: (1998) Nature 395, 698-702[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "698-702"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.282: Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B., and Takashima, A. 

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "S."

Phrase: ","

Phrase: "Palacino,"

Phrase: "J.,"

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.283: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.284: 433, 73-77[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "433,"

Phrase: "73-77"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.285: Nishimura, M, Yu, G., Levesque, G., Zhang, D. 

Phrase: "Nishimura,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "D."
Processing 00000000.tx.286: M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., Jo, E., Supala, A., Rogaeva, E., Xu, D.-M., Janus, C., Levesque, L., Bi, Q., Duthie, M., Rozmahel, R., Mattila, K., Lannfelt, L., Westaway, D., Mount, H. 

Phrase: "M."

Phrase: ","

Phrase: "Ruel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Milman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Holmes,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Kawarai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "E.,"

Phrase: "Supala,"

Phrase: "A.,"

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "D.-"

Phrase: "M."

Phrase: ","

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bi,"

Phrase: "Q.,"

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "Rozmahel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mattila,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.287: T.J., Woodgett, J., Fraser, P. 

Phrase: "T.J.,"

Phrase: "Woodgett,"

Phrase: "J.,"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: E., and St. 

Phrase: "E.,"

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.289: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.290: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.291: Med. 

Phrase: "Med."
Processing 00000000.tx.292: 5, 164-169[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "164-169"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.293: Kang, D. 

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.294: E., Soriano, S., Frosch, M. 

Phrase: "E.,"

Phrase: "Soriano,"

Phrase: "S."

Phrase: ","

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: P., Collins, T., Naruse, S., Sisodia, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.296: S., Leibowitz, G., Levine, F., and Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Leibowitz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Levine,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.297: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.298: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.299: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.300: 19, 4229-4237[Abstract/Free FullText] 20. 

Phrase: "19,"

Phrase: "4229-4237"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.301: Stahl, B., Diehlmann, A., and Sdhof, T. 

Phrase: "Stahl,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehlmann,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.302: C. 

Phrase: "C."
Processing 00000000.tx.303: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.304: Biol. 

Phrase: "Biol."
Processing 00000000.tx.305: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.306: 274, 9141-9148[Abstract/Free FullText] 21. 

Phrase: "274,"

Phrase: "9141-9148"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.307: Xia, W., Zhang, J., Perez, R., Koo, E. 

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Perez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.308: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.309: J. 

Phrase: "J."
Processing 00000000.tx.310: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.311: Natl. 

Phrase: "Natl."
Processing 00000000.tx.312: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.313: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.314: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.315: 94, 8208-8213[Abstract/Free FullText] 22. 

Phrase: "94,"

Phrase: "8208-8213"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.316: Zhang, W., Han, S. 

Phrase: "Zhang,"

Phrase: "W.,"

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: W., McKeel, D. 

Phrase: "W., McKeel,"

Phrase: "D."
Processing 00000000.tx.318: W., Goate, A., and Wu, J. 

Phrase: "W., Goate,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.319: Y. 

Phrase: "Y."
Processing 00000000.tx.320: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.321: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.322: 18, 914-922[Abstract/Free FullText] 23. 

Phrase: "18,"

Phrase: "914-922"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.323: Ray, W. 

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W."
Processing 00000000.tx.324: J., Yao, M., Nowotny, P., Mumm, J., Zhang, W., Wu, J. 

Phrase: "J.,"

Phrase: "Yao,"

Phrase: "M."

Phrase: ","

Phrase: "Nowotny,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mumm,"

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "W.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.325: Y., Kopan, R., and Goate, A. 

Phrase: "Y.,"

Phrase: "Kopan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.326: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.327: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.328: Natl. 

Phrase: "Natl."
Processing 00000000.tx.329: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.330: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.331: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.332: 96, 3263-3268[Abstract/Free FullText] 24. 

Phrase: "96,"

Phrase: "3263-3268"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.333: Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. 

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kohno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sugihara,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.334: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.335: Natl. 

Phrase: "Natl."
Processing 00000000.tx.336: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.337: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.338: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.339: 95, 9637-9641[Abstract/Free FullText] 25. 

Phrase: "95,"

Phrase: "9637-9641"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.340: Dumanchin, C., Czech, C., Campion, D., Cuif, M. 

Phrase: "Dumanchin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Cuif,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: H., Poyot, T., Martin, C., Charbonnier, F., Goud, B., Pradier, L., and Frebourg, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Poyot,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Charbonnier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Goud,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Frebourg,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.342: (1999) Hum. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.343: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.344: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.345: 8, 1263-1269[Abstract/Free FullText] 26. 

Phrase: "8,"

Phrase: "1263-1269"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.346: Buxbaum, J. 

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.347: D., Choi, E.-K., Luo, Y., Lilliehook, C., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Choi,"

Phrase: "E.-K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Lilliehook,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.348: C., Merriam, D. 

Phrase: "C., Merriam,"

Phrase: "D."
Processing 00000000.tx.349: E., and Wasco, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.350: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.351: Med. 

Phrase: "Med."
Processing 00000000.tx.352: 4, 1177-1181[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "4,"

Phrase: "1177-1181"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.353: Stabler, S. 

Phrase: "Stabler, S."
Processing 00000000.tx.354: M., Ostrowski, L. 

Phrase: "M."

Phrase: ","

Phrase: "Ostrowski,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.355: L., Janicki, S. 

Phrase: "L., Janicki,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.356: M., and Monteiro, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Monteiro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: J. 

Phrase: "J."
Processing 00000000.tx.358: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.359: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.360: 145, 1277-1292[Abstract/Free FullText] 28. 

Phrase: "145,"

Phrase: "1277-1292"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.361: Imafuku, I., Masaki, T., Waragai, M., Takeuchi, S., Kawabata, M., Hirai, S.-I., Ohno, S., Nee, L. 

Phrase: "Imafuku,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Masaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1461631:masaki [Plant]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Waragai,"

Phrase: "M."

Phrase: ","

Phrase: "Takeuchi,"

Phrase: "S."

Phrase: ","

Phrase: "Kawabata,"

Phrase: "M."

Phrase: ","

Phrase: "Hirai,"

Phrase: "S.-I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ohno,"

Phrase: "S."

Phrase: ","

Phrase: "Nee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.362: E., Lippa, C. 

Phrase: "E.,"

Phrase: "Lippa,"

Phrase: "C."
Processing 00000000.tx.363: F., Kanazawa, I., Imagawa, M., and Okazawa, H. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kanazawa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Imagawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Okazawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.364: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.365: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.366: 147, 121-133[Abstract/Free FullText] 29. 

Phrase: "147,"

Phrase: "121-133"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.367: Passer, B. 

Phrase: "Passer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0491928:PASSER [Medical Device]
  1000   C0999347:Passer [Bird]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.368: J., Pellegrini, L., Vito, P., Ganjei, J. 

Phrase: "J.,"

Phrase: "Pellegrini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ganjei,"

Phrase: "J."
Processing 00000000.tx.369: K., and D'Adamio, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.370: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.371: Biol. 

Phrase: "Biol."
Processing 00000000.tx.372: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.373: 274, 24007-24013[Abstract/Free FullText] 30. 

Phrase: "274,"

Phrase: "24007-24013"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.374: Thinakaran, G., Borcehlt, D., Lee, M., Slunt, H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borcehlt,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.375: L., Gandy, S. 

Phrase: "L., Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: E., Jenkinds, N. 

Phrase: "E.,"

Phrase: "Jenkinds,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.377: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.378: G., Price, D., L., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.380: (1996) Neuron 17, 181-190[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.381: Mercken, M., Takahashi, H., Honda, T., Sato, K., Murayama, M., Nakazato, Y., Noguchi, K., Imahori, K., and Takashima, A. 

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Nakazato,"

Phrase: "Y.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Imahori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.382: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.383: 389, 297-303[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "389,"

Phrase: "297-303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.384: Kim, T.-W., Pettingell, W. 

Phrase: "Kim,"

Phrase: "T.-W., Pettingell,"

Phrase: "W."
Processing 00000000.tx.385: H., Hallmark, O. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hallmark,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.386: G., Moir, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.387: D., Wasco, W., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.388: E. 

Phrase: "E."
Processing 00000000.tx.389: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Biol. 

Phrase: "Biol."
Processing 00000000.tx.391: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.392: 272, 11006-11010[Abstract/Free FullText] 33. 

Phrase: "272,"

Phrase: "11006-11010"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.393: Seeger, M., Nordstedt, C., Petanceska, S., Kovacs, D. 

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Petanceska,"

Phrase: "S."

Phrase: ","

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.394: M., Gouras, G. 

Phrase: "M."

Phrase: ","

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: K., Hahne, S., Fraser, P., Levesque, L., Czernik, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hahne,"

Phrase: "S."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Czernik,"

Phrase: "A."
Processing 00000000.tx.396: J., St. 

Phrase: "J.,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.397: George-Hyslop, P., Sisodia, S. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.398: S., Thinakaran, G., Tanzi, R. 

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: E., Greengard, P., and Gandy, P. 

Phrase: "E.,"

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.400: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.401: Natl. 

Phrase: "Natl."
Processing 00000000.tx.402: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.403: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.404: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.405: 94, 5090-5094[Abstract/Free FullText] 34. 

Phrase: "94,"

Phrase: "5090-5094"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.406: Thinakaran, G., Regard, J. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Regard,"

Phrase: "J."
Processing 00000000.tx.407: B., Bouton, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bouton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206181:bouton [Cell Component]

Phrase: "C."
Processing 00000000.tx.408: M.L., Harris, C. 

Phrase: "M.L., Harris,"

Phrase: "C."
Processing 00000000.tx.409: L., Price, D. 

Phrase: "L., Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.410: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.411: R., and Sisodia, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.413: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.414: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.415: 4, 438-453[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "4,"

Phrase: "438-453"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.416: Capell, A., Grnberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R., Beyreuther, K., Selkoe, D. 

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Grnberg,"

Phrase: "J.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehlmann,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Nixon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.417: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.418: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.419: Biol. 

Phrase: "Biol."
Processing 00000000.tx.420: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.421: 273, 3205-3211[Abstract/Free FullText] 36. 

Phrase: "273,"

Phrase: "3205-3211"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.422: Marambaud, P., Ancolio, K., Lopez-Perez, E., and Checler, F. 

Phrase: "Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lopez-Perez,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.423: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.424: Med. 

Phrase: "Med."
Processing 00000000.tx.425: 4, 147-157[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "4,"

Phrase: "147-157"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.426: Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Takahashi, H., Murayama, O., Murayama, M., Sato, K., Omori, A., Tsubuki, S., Saido, T. 

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Omori,"

Phrase: "A.,"

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.427: C., and Takashima, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.428: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.430: 72, 255-261[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "72,"

Phrase: "255-261"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.431: Fraser, P. 

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.432: E., Levesque, G., Yu, G., Mills, L. 

Phrase: "E.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.433: R., Thirwell, J., Frantseva, M., Gandy, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thirwell,"

Phrase: "J.,"

Phrase: "Frantseva,"

Phrase: "M."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: E., Seeger, M., Carlen, P. 

Phrase: "E.,"

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Carlen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.435: L., and St. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.436: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.437: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.438: Aging 19, 19-21[CrossRef] 39. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "19,"

Phrase: "19-21"

Phrase: "[CrossRef"

Phrase: "] 39."
Processing 00000000.tx.439: Meyers, M. 

Phrase: "Meyers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: B., Pickel, V. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pickel,"

Phrase: "V."
Processing 00000000.tx.441: M., Sheu, S.-S., Sharma, V. 

Phrase: "M."

Phrase: ","

Phrase: "Sheu,"

Phrase: "S.-S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sharma,"

Phrase: "V."
Processing 00000000.tx.442: K., Scotto, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Scotto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.443: W., and Fishman, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Fishman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.444: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.445: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.446: Biol. 

Phrase: "Biol."
Processing 00000000.tx.447: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.448: 270, 26411-26418[Abstract/Free FullText] 40. 

Phrase: "270,"

Phrase: "26411-26418"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.449: Van der Bliek, A. 

Phrase: "Van der Bliek,"

Phrase: "A."
Processing 00000000.tx.450: M., Meyers, M. 

Phrase: "M."

Phrase: ","

Phrase: "Meyers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.451: B., Biedler, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Biedler,"

Phrase: "J."
Processing 00000000.tx.452: L., Hes, E., and Borst, P. 

Phrase: "L., Hes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495434:HES [Carbohydrate,Pharmacologic Substance]

Phrase: "E.,"

Phrase: "and"

Phrase: "Borst,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.453: (1986) EMBO J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.454: 5, 3201-3208[Abstract] 41. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3201-3208"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 41."
Processing 00000000.tx.455: Maki, M., Narayama, S. 

Phrase: "Maki,"

Phrase: "M."

Phrase: ","

Phrase: "Narayama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.456: V.L., and Hitomi, K. 

Phrase: "V.L.,"

Phrase: "and"

Phrase: "Hitomi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.457: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.458: J. 

Phrase: "J."
Processing 00000000.tx.459: 328, 718-720[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "328,"

Phrase: "718-720"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.460: Lokuta, A. 

Phrase: "Lokuta,"

Phrase: "A."
Processing 00000000.tx.461: J., Meyers, M. 

Phrase: "J.,"

Phrase: "Meyers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.462: B., Sanders, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.463: R., Fishman, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fishman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.464: I., and Valdivia, H. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Valdivia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1204228:Valdivia [Plant]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.465: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.466: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.469: 272, 25333-25338[Abstract/Free FullText] 43. 

Phrase: "272,"

Phrase: "25333-25338"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.470: Valdivia, H. 

Phrase: "Valdivia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1204228:Valdivia [Plant]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.471: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.472: (1998) Trends Pharmacol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.473: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.474: 19, 479-482[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "19,"

Phrase: "479-482"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.475: Pickel, V. 

Phrase: "Pickel,"

Phrase: "V."
Processing 00000000.tx.476: M., Clarke, C. 

Phrase: "M."

Phrase: ","

Phrase: "Clarke,"

Phrase: "C."
Processing 00000000.tx.477: L., and Meyers, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Meyers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.479: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.480: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.481: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.482: 386, 625-634[CrossRef][Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "386,"

Phrase: "625-634"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.483: Boyhan, A., Casimir, C. 

Phrase: "Boyhan,"

Phrase: "A.,"

Phrase: "Casimir,"

Phrase: "C."
Processing 00000000.tx.484: M., French, J. 

Phrase: "M."

Phrase: ","

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "J."
Processing 00000000.tx.485: K., Teahan, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Teahan,"

Phrase: "C."
Processing 00000000.tx.486: G., and Segal, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Segal,"

Phrase: "A."
Processing 00000000.tx.487: W. 

Phrase: "W."
Processing 00000000.tx.488: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.489: Biol. 

Phrase: "Biol."
Processing 00000000.tx.490: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.491: 267, 2928-2933[Abstract/Free FullText] 46. 

Phrase: "267,"

Phrase: "2928-2933"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.492: Tomita, T., Maruyama, K., Saido, T. 

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.493: C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grnberg, J., Haass, C., Iwatsubo, T., and Obata, K. 

Phrase: "C., Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grnberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.494: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.495: Natl. 

Phrase: "Natl."
Processing 00000000.tx.496: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.497: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.498: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.499: 94, 2025-2030[Abstract/Free FullText] 47. 

Phrase: "94,"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.500: Brownawell, A. 

Phrase: "Brownawell,"

Phrase: "A."
Processing 00000000.tx.501: M., and Creutz, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Creutz,"

Phrase: "C."
Processing 00000000.tx.502: E. 

Phrase: "E."
Processing 00000000.tx.503: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.504: Biol. 

Phrase: "Biol."
Processing 00000000.tx.505: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.506: 272, 22182-22190[Abstract/Free FullText] 48. 

Phrase: "272,"

Phrase: "22182-22190"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.507: Hammond, C., and Helenius, A. 

Phrase: "Hammond,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Helenius,"

Phrase: "A."
Processing 00000000.tx.508: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.509: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.510: 126, 41-52[Abstract] 49. 

Phrase: "126,"

Phrase: "41-52"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 49."
Processing 00000000.tx.511: Kim, M., Velier, J., Chase, K., Laforet, G., Kalchman, M. 

Phrase: "Kim,"

Phrase: "M."

Phrase: ","

Phrase: "Velier,"

Phrase: "J.,"

Phrase: "Chase,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laforet,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kalchman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: A., Hayden, M. 

Phrase: "A.,"

Phrase: "Hayden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.513: R., Won, L., Heller, A., Aronin, N., and DiFiglia, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Won,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1555430:Won [Quantitative Concept]
   966 E C3538717:WIN [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Heller,"

Phrase: "A.,"

Phrase: "Aronin,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "DiFiglia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.514: (1999) Neuroscience 89, 1159-1167[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuroscience 89,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "1159-1167"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.515: Creutz, C. 

Phrase: "Creutz,"

Phrase: "C."
Processing 00000000.tx.516: E. 

Phrase: "E."
Processing 00000000.tx.517: (1992) Science 258, 924-931[Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "924-931"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.518: Meyers, M. 

Phrase: "Meyers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: B., Zamparelli, C., Verzili, D., Dicker, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zamparelli,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Verzili,"

Phrase: "D."

Phrase: ","

Phrase: "Dicker"

Phrase: ","

Phrase: "A."
Processing 00000000.tx.520: P., Blanck, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Blanck,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.521: J., and Chiancone, E. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Chiancone,"

Phrase: "E."
Processing 00000000.tx.522: (1995) FEBS Lett. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.523: 357, 230-234[CrossRef][Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "357,"

Phrase: "230-234"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.524: Doan, A., Thinakaran, G., Borchelt, D. 

Phrase: "Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.525: R., Slunt, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.526: H., Ratovitsky, T., Podlisny, M., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Podlisny,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.527: J., Seeger, M., Gandy, S. 

Phrase: "J.,"

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.528: E., Price, D. 

Phrase: "E.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.529: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.530: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.531: (1996) Neuron 7, 1023-1030 53. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1023-1030 53."
Processing 00000000.tx.532: Kim, T.-W., Pettingell, W. 

Phrase: "Kim,"

Phrase: "T.-W., Pettingell,"

Phrase: "W."
Processing 00000000.tx.533: H., Jung, Y.-K., Kovacs, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jung,"

Phrase: "Y.-K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.534: M., and Tanzi, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.535: E. 

Phrase: "E."
Processing 00000000.tx.536: (1997) Science 277, 373-376[Abstract/Free FullText] 54. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 277,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "373-376"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.537: Alkon, D. 

Phrase: "Alkon,"

Phrase: "D."
Processing 00000000.tx.538: L., Nelson, T. 

Phrase: "L., Nelson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.539: J., Zhao, W., and Cavallaro, S. 

Phrase: "J.,"

Phrase: "Zhao,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Cavallaro,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.540: (1998) Trends Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.541: 21, 529-537[CrossRef][Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "21,"

Phrase: "529-537"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.542: Berridge, M. 

Phrase: "Berridge,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: J. 

Phrase: "J."
Processing 00000000.tx.544: (1998) Neuron 21, 13-26[Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 21,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "13-26"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.545: Balschun, D., Wolfer, D. 

Phrase: "Balschun,"

Phrase: "D."

Phrase: ","

Phrase: "Wolfer,"

Phrase: "D."
Processing 00000000.tx.546: P., Bertocchini, F., Barone, B., Conti, A., Zuschratter, W., Missiaen, L., Lipp, H.-P., Frey, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bertocchini,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Barone,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Conti,"

Phrase: "A.,"

Phrase: "Zuschratter,"

Phrase: "W.,"

Phrase: "Missiaen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lipp,"

Phrase: "H.-P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Frey,"

Phrase: "J."
Processing 00000000.tx.547: U., and Sorrentino, V. 

Phrase: "U.,"

Phrase: "and"

Phrase: "Sorrentino,"

Phrase: "V."
Processing 00000000.tx.548: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.549: 18, 5264-5273[Abstract/Free FullText] 57. 

Phrase: "18,"

Phrase: "5264-5273"

Phrase: "[Abstract/Free FullText"

Phrase: "] 57."
Processing 00000000.tx.550: Cameron, A. 

Phrase: "Cameron,"

Phrase: "A."
Processing 00000000.tx.551: M., Steiner, J. 

Phrase: "M."

Phrase: ","

Phrase: "Steiner,"

Phrase: "J."
Processing 00000000.tx.552: P., Roskams, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roskams,"

Phrase: "A."
Processing 00000000.tx.553: J., Ali, S. 

Phrase: "J.,"

Phrase: "Ali,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: M., Ronnett, G. 

Phrase: "M."

Phrase: ","

Phrase: "Ronnett,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.555: V., and Snyder, S. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.556: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.557: (1995) Cell 83, 463-472[Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 83,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "463-472"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.558: Saura, C. 

Phrase: "Saura,"

Phrase: "C."
Processing 00000000.tx.559: A., Taisuke, T., Iwatsubo, T., and Thinakaran, G. 

Phrase: "A.,"

Phrase: "Taisuke,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.560: (1999) Soc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Soc."
Processing 00000000.tx.561: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.562: Abstr. 

Phrase: "Abstr."
Processing 00000000.tx.563: 25, 56 59. 

Phrase: "25,"

Phrase: "56 59."
Processing 00000000.tx.564: Querfurth, H. 

Phrase: "Querfurth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.565: W., Jiang, J., Geiger, J. 

Phrase: "W., Jiang,"

Phrase: "J.,"

Phrase: "Geiger,"

Phrase: "J."
Processing 00000000.tx.566: D., and Selkoe, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.567: J. 

Phrase: "J."
Processing 00000000.tx.568: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.569: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.570: 69, 1580-1591[Medline] [OrderarticleviaInfotrieve] 60. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "1580-1591"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 60."
Processing 00000000.tx.571: Kelliher, M., Fastbom, J., Cowburn, R. 

Phrase: "Kelliher,"

Phrase: "M."

Phrase: ","

Phrase: "Fastbom,"

Phrase: "J.,"

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.572: F., Bonkale, W., Ohm, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bonkale,"

Phrase: "W.,"

Phrase: "Ohm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560037:ohm [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.573: G., Ravid, R., Sorrentino, V., and O'Neill, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sorrentino,"

Phrase: "V.,"

Phrase: "and"

Phrase: "O'Neill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.574: (1999) Neuroscience 92, 499-513[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuroscience 92,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "499-513"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

